Coronary Disease

• 

  Subject Areas on Research

  • "Functional characteristics of a new perfusion balloon: comparison with the Flowtrack 40 in a closed chest swine". 
  • "Left main equivalent" coronary artery disease: its clinical presentation and prognostic significance with nonsurgical therapy. 
  • 27th Bethesda Conference: matching the intensity of risk factor management with the hazard for coronary disease events. Task Force 5. Stratification of patients into high, medium and low risk subgroups for purposes of risk factor management. 
  • A Bayesian approach to aid in formulary decision making: incorporating institution-specific cost-effectiveness data with clinical trial results. 
  • A case for nonionic contrast media--despite the high cost. 
  • A clinical comparison of mitral valve repair versus valve replacement in ischemic mitral regurgitation. 
  • A clinical investigation on tong xin luo capsule in treatment of coronary heart disease with silent myocardial ischemia. 
  • A comparison of U.S. and Canadian cardiac catheterization practices in detecting severe coronary artery disease after myocardial infarction: efficiency, yield and long-term implications. 
  • A comparison of administrative versus clinical data: coronary artery bypass surgery as an example. Ischemic Heart Disease Patient Outcomes Research Team. 
  • A comparison of clinical outcomes between Canadian and American patients after nonurgent coronary stenting. 
  • A comparison of directional atherectomy with coronary angioplasty in patients with coronary artery disease. The CAVEAT Study Group. 
  • A comparison of frequency distributions for use in a model for selecting treatment in coronary artery disease. 
  • A comparison of live counseling with a web-based lifestyle and medication intervention to reduce coronary heart disease risk: a randomized clinical trial. 
  • A comparison of neural network models for the prediction of the cost of care for acute coronary syndrome patients. 
  • A comparison of the costs of and quality of life after coronary angioplasty or coronary surgery for multivessel coronary artery disease. Results from the Emory Angioplasty Versus Surgery Trial (EAST). 
  • A data-based approach to assessing clinical interventions in the setting of chronic disease. 
  • A deep-learning system for the assessment of cardiovascular disease risk via the measurement of retinal-vessel calibre. 
  • A dynamic analysis of chronic disease development: a study of sex specific changes in coronary heart disease incidence and risk factors in Framingham. 
  • A genetic risk score based on direct associations with coronary heart disease improves coronary heart disease risk prediction in the Atherosclerosis Risk in Communities (ARIC), but not in the Rotterdam and Framingham Offspring, Studies. 
  • A genetic risk score is associated with incident cardiovascular disease and coronary artery calcium: the Framingham Heart Study. 
  • A mathematical approach to medical decisions: application of Bayes' rule to a mixture of continuous and discrete clinical variables. 
  • A mathematical model of the physiological dynamics of aging and correlated mortality selection: II. Application to the Duke Longitudinal Study. 
  • A meta-analysis of randomized trials of calcium antagonists to reduce restenosis after coronary angioplasty. 
  • A method for quantitating antifibrillatory effects of drugs after coronary reperfusion in dogs: improved outcome with bretylium. 
  • A multidimensional integrative medicine intervention to improve cardiovascular risk. 
  • A multiple cause of death analysis of hypertension-related mortality in North Carolina, 1968-1977. 
  • A new information system for medical practice. 
  • A noninvasive radiographic technique for evaluation of exercise-induced changes in cardiac function. 
  • A note on sample size calculation for mean comparisons based on noncentral t-statistics. 
  • A path model of chronic stress, the metabolic syndrome, and coronary heart disease. 
  • A perspective on trials comparing enoxaparin and unfractionated heparin in the treatment of non-ST-elevation acute coronary syndromes. 
  • A pooled analysis of coronary arterial patency and left ventricular function after intravenous thrombolysis for acute myocardial infarction. 
  • A primer of biostatistic and economic methods for diagnostic and prognostic modeling in nuclear cardiology: Part I. 
  • A randomized comparison of the effects of gradual prolonged versus standard primary balloon inflation on early and late outcome. Results of a multicenter clinical trial. Perfusion Balloon Catheter Study Group. 
  • A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. 
  • A randomized study would answer the question. 
  • A randomized trial comparing coronary angioplasty with coronary bypass surgery. Emory Angioplasty versus Surgery Trial (EAST). 
  • A randomized trial of a strategy for increasing high-density lipoprotein cholesterol levels: effects on progression of coronary heart disease and clinical events. 
  • A randomized trial of vascular hemostasis techniques to reduce femoral vascular complications after coronary intervention. 
  • A randomized, double-blind, placebo-controlled, multicenter study to evaluate the cardioprotective effects of MC-1 in patients undergoing high-risk coronary artery bypass graft surgery: MC-1 to Eliminate Necrosis and Damage in Coronary Artery Bypass Graft Surgery Trial (MEND-CABG) II--study design and rationale. 
  • A randomized, placebo-controlled trial of enoxaparin after high-risk coronary stenting: the ATLAST trial. 
  • A rapid troponin I assay is not optimal for determination of troponin status and prediction of subsequent cardiac events at suspicion of unstable coronary syndromes. 
  • A regression model for longitudinal change in the presence of measurement error. 
  • A symposium: safety issues concerning the use of glycoprotein IIb-IIIa inhibitors in the management of acute coronary syndromes. 
  • A tale of two countries: Insights from the differences in Canadian/American patterns of care for patients with acute coronary syndromes. 
  • A telephone-delivered intervention for patients with NIDDM. Effect on coronary risk factors. 
  • A theoretical model of the physiological dynamics of circulatory disease in human populations. 
  • ACC/AHA Guidelines for Exercise Testing. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing). 
  • ACC/AHA guidelines for exercise testing: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing). 
  • ACCF/ACR/AHA/NASCI/SAIP/SCAI/SCCT 2010 expert consensus document on coronary computed tomographic angiography: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. 
  • ACCF/ACR/AHA/NASCI/SAIP/SCAI/SCCT 2010 expert consensus document on coronary computed tomographic angiography: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. 
  • ACCF/AHA/SCAI 2007 update of the Clinical Competence Statement on Cardiac Interventional Procedures: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and Training (Writing Committee to Update the 1998 Clinical Competence Statement on Recommendations for the Assessment and Maintenance of Proficiency in Coronary Interventional Procedures). 
  • ACCF/AHA/SCAI 2007 update of the clinical competence statement on cardiac interventional procedures: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and Training (writing Committee to Update the 1998 Clinical Competence Statement on Recommendations for the Assessment and Maintenance of Proficiency in Coronary Interventional Procedures). 
  • ACCF/ASE/ACEP/AHA/ASNC/SCAI/SCCT/SCMR 2008 appropriateness criteria for stress echocardiography: a report of the American College of Cardiology Foundation Appropriateness Criteria Task Force, American Society of Echocardiography, American College of Emergency Physicians, American Heart Association, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance endorsed by the Heart Rhythm Society and the Society of Critical Care Medicine. 
  • ACCF/ASE/ACEP/AHA/ASNC/SCAI/SCCT/SCMR 2008 appropriateness criteria for stress echocardiography: a report of the American College of Cardiology Foundation Appropriateness Criteria Task Force, American Society of Echocardiography, American College of Emergency Physicians, American Heart Association, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance: endorsed by the Heart Rhythm Society and the Society of Critical Care Medicine. 
  • ACCF/ASNC appropriateness criteria for single-photon emission computed tomography myocardial perfusion imaging (SPECT MPI): a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group and the American Society of Nuclear Cardiology endorsed by the American Heart Association. 
  • ACCF/SCAI/STS/AATS/AHA/ASNC 2009 Appropriateness Criteria for Coronary Revascularization : a report of the American College of Cardiology Foundation Appropriateness Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, and the American Society of Nuclear Cardiology. Endorsed by the American Society of Echocardiography, the Heart Failure Society of America, and the Society of Cardiovascular Computed Tomography. 
  • ACCF/SCAI/STS/AATS/AHA/ASNC/HFSA/SCCT 2012 Appropriate use criteria for coronary revascularization focused update: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, American Society of Nuclear Cardiology, and the Society of Cardiovascular Computed Tomography. 
  • ACCF/SCCT/ACR/AHA/ASE/ASNC/NASCI/SCAI/SCMR 2010 Appropriate Use Criteria for Cardiac Computed Tomography. A Report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, the Society of Cardiovascular Computed Tomography, the American College of Radiology, the American Heart Association, the American Society of Echocardiography, the American Society of Nuclear Cardiology, the North American Society for Cardiovascular Imaging, the Society for Cardiovascular Angiography and Interventions, and the Society for Cardiovascular Magnetic Resonance. 
  • ACCF/SCCT/ACR/AHA/ASE/ASNC/NASCI/SCAI/SCMR 2010 appropriate use criteria for cardiac computed tomography. A report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, the Society of Cardiovascular Computed Tomography, the American College of Radiology, the American Heart Association, the American Society of Echocardiography, the American Society of Nuclear Cardiology, the North American Society for Cardiovascular Imaging, the Society for Cardiovascular Angiography and Interventions, and the Society for Cardiovascular Magnetic Resonance. 
  • ACE inhibitors in hypertension: a US perspective. 
  • AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases. American Heart Association Science Advisory and Coordinating Committee. 
  • ASPIRE-2-PREVENT: a survey of lifestyle, risk factor management and cardioprotective medication in patients with coronary heart disease and people at high risk of developing cardiovascular disease in the UK. 
  • AZD6140. 
  • Abciximab readministration: results of the ReoPro Readministration Registry. 
  • Abciximab therapy and unplanned coronary stent deployment: favorable effects on stent use, clinical outcomes, and bleeding complications. EPILOG Trial Investigators. 
  • Absence of sex bias in the referral of patients for cardiac catheterization. 
  • Accuracy and interobserver variability of coronary cineangiography: a comparison with postmortem evaluation. 
  • Achieving optimal results with standard balloon angioplasty: can baseline and angiographic variables predict stent-like outcomes? 
  • Achieving the Full "PROMISE" of Imaging Outcomes Research. 
  • Acute and long-term cost implications of coronary stenting. 
  • Acute complications of excimer laser coronary angioplasty: a detailed analysis of multicenter results. Coinvestigators of the U.S. and European Percutaneous Excimer Laser Coronary Angioplasty (PELCA) Registries. 
  • Acute coronary findings at autopsy in heart failure patients with sudden death: results from the assessment of treatment with lisinopril and survival (ATLAS) trial. 
  • Acute coronary syndromes and diabetes mellitus. 
  • Acute coronary syndromes in the GUSTO-IIb trial: prognostic insights and impact of recurrent ischemia. The GUSTO-IIb Investigators. 
  • Acute effects of ethanol on myocardial blood flow in the nonischemic and ischemic heart. 
  • Acute platelet inhibition with abciximab does not reduce in-stent restenosis (ERASER study). The ERASER Investigators. 
  • Acute reduction of lipoprotein(a) by tissue-type plasminogen activator. 
  • Acute ventricular wall motion heterogeneity. A valuable but imperfect index of myocardial ischemia. 
  • Addition of right-sided and posterior precordial leads during stress testing. 
  • Adenoviral-mediated gene transfer induces sustained pericardial VEGF expression in dogs: effect on myocardial angiogenesis. 
  • Adherence to evidence-based therapies after discharge for acute coronary syndromes: an ongoing prospective, observational study. 
  • Administration of thrombolytic therapy in the community hospital: established principles and unresolved issues. 
  • Adult height, coronary heart disease and stroke: a multi-locus Mendelian randomization meta-analysis. 
  • Advanced coronary artery disease: Appropriate end points for trials of novel therapies. 
  • Advances in the approach to acute coronary syndromes. 
  • Adverse baseline physiological and psychosocial profiles of women enrolled in a cardiac rehabilitation clinical trial. 
  • Aerobic exercise reduces levels of cardiovascular and sympathoadrenal responses to mental stress in subjects without prior evidence of myocardial ischemia. 
  • Age moderates the short-term effects of transdermal 17beta-estradiol on endothelium-dependent vascular function in postmenopausal women. 
  • Age, Race and Cardiovascular Outcomes in African American Veterans. 
  • Age-related macular degeneration and incident cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis. 
  • Age-related macular degeneration and risk of coronary heart disease and stroke: the Cardiovascular Health Study. 
  • Aggressive lipid lowering in postcoronary angioplasty patients with elevated cholesterol (the Lovastatin Restenosis Trial). 
  • Aggressive therapy of acute MI in the elderly. 
  • Aggressive treatment of high-density lipoprotein cholesterol. 
  • Alcohol consumption is negatively associated with the prevalence of coronary heart disease in the New Mexico Elder Health Survey. 
  • Allostatic load in the association of depressive symptoms with incident coronary heart disease: The Jackson Heart Study. 
  • Alteration of digoxin pharmacokinetics by a single dose of quinidine. 
  • Alternative conduits for coronary revascularization: a novel approach for harvest of the lesser saphenous vein. 
  • American College of Cardiology key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes. A report of the American College of Cardiology Task Force on Clinical Data Standards (Acute Coronary Syndromes Writing Committee). 
  • American College of Cardiology/ European Society of Cardiology international study of angiographic data compression phase I. The effects of lossy data compression on recognition of diagnostic features in digital coronary angiography. 
  • American College of Cardiology/American Heart Association Expert Consensus Document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease. 
  • American College of Cardiology/American Heart Association Expert Consensus document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease. 
  • American College of Cardiology/American Heart Association clinical competence statement on echocardiography: a report of the American College of Cardiology/American Heart Association/American College of Physicians--American Society of Internal Medicine Task Force on Clinical Competence. 
  • American College of Cardiology/European Society of Cardiology International Study of Angiographic Data Compression Phase I: The effect of lossy data compression on recognition of diagnostic features in digital coronary angiography. 
  • An "almost exhaustive" search-based sequential permutation method for detecting epistasis in disease association studies. 
  • An alternative pseudolikelihood method for multivariate random-effects meta-analysis. 
  • An automated strategy for bedside aPTT determination and unfractionated heparin infusion adjustment in acute coronary syndromes: insights from PARAGON A. 
  • An improving prognosis over time in medically treated patients with coronary artery disease. 
  • An mHealth Intervention to Improve Medication Adherence and Health Outcomes Among Patients With Coronary Heart Disease: Randomized Controlled Trial. 
  • An overview of risk assessment in coronary artery disease. 
  • An unexpected flow abnormality. 
  • Anaemia and coronary artery disease severity in patients with heart failure. 
  • Analysis of cardiac arrhythmias during dobutamine pharmacologic stress testing in nuclear cardiology as related to the presence or absence of baseline arrhythmias. 
  • Analysis of the components of CHD risk in the Framingham study: new multivariate procedures for the analysis of chronic disease development. 
  • Anatomic and prognostic implications of an early positive treadmill exercise test. 
  • Aneurysm of a saphenous vein bypass graft associated with aneurysms of native coronary arteries. 
  • Anger proneness predicts coronary heart disease risk: prospective analysis from the atherosclerosis risk in communities (ARIC) study. 
  • Angina, myocardial ischemia and coronary disease: gold standards, operational definitions and correlations. 
  • Angioplasty or surgery for multivessel coronary artery disease: comparison of eligible registry and randomized patients in the EAST trial and influence of treatment selection on outcomes. Emory Angioplasty versus Surgery Trial Investigators. 
  • Angiotensin as local modulating factor in ventricular dysfunction and failure due to coronary artery disease. 
  • Angiotensin converting enzyme inhibitors and the cardiovascular system. 
  • Antibiotics and coronary heart disease. 
  • Antiplatelet and antithrombin therapies in the acute coronary syndromes. 
  • Antipsychotic effects on estimated 10-year coronary heart disease risk in the CATIE schizophrenia study. 
  • Antithrombotic therapy in patients undergoing coronary angioplasty. 
  • Antithrombotic therapy in patients undergoing coronary angioplasty. 
  • Antithrombotic therapy in patients undergoing percutaneous coronary intervention. 
  • Anxiety, depression, and heart rate variability. 
  • Anxiety-proneness and coronary heart disease. 
  • Anxiety-proneness and coronary heart disease. 
  • Aortocoronary bypass grafting in patients without left main stenosis. Relation of risk factors to early and late survival. 
  • Aortocoronary bypass surgery: Correlation of angiographic symptomatic and functional improvement at 1 year. 
  • Apolipoprotein B improves risk assessment of future coronary heart disease in the Framingham Heart Study beyond LDL-C and non-HDL-C. 
  • Application of quantitative coronary angiography in a cineless environment: in vivo assessment of a fully automated system for clinical use. 
  • Appropriate Use of Cardiac Stress Testing with Imaging: A Systematic Review and Meta-Analysis. 
  • Aspects of social support associated with depression at hospitalization and follow-up assessment among cardiac patients. 
  • Aspirin resistance and a single gene. 
  • Aspirin use and outcomes in a community-based cohort of 7352 patients discharged after first hospitalization for heart failure. 
  • Aspirin use post-acute coronary syndromes: intolerance, bleeding and discontinuation. 
  • Assessing risk for coronary heart disease: beyond Framingham. 
  • Assessing the clinical and economic burden of coronary artery disease: 1986-1998. 
  • Assessing the value of newer pharmacologic agents in non-ST elevation patients: a decision support system application. 
  • Assessment of conceptual tempo in the type A (coronary prone) behavior pattern. 
  • Assessment of left ventricular pressure-volume relations using gated radionuclide angiography, echocardiography, and micromanometer pressure recordings. A new method for serial measurements of systolic and diastolic function in man. 
  • Assessment of regional left ventricular function using gated radionuclide angiography. 
  • Assessment of the use of the age- and sex-specific United States population as a control group for analysis of survival in coronary artery disease. 
  • Assessment of ventricular function in coronary artery disease by means of atrial pacing and exercise. 
  • Association Between Depressive Symptoms and Incident Cardiovascular Diseases. 
  • Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data. 
  • Association between admission white blood cell count and one-year mortality in patients with acute coronary syndromes. 
  • Association of Cardiovascular Outcomes With Masked Hypertension Defined by Home Blood Pressure Monitoring in a Japanese General Practice Population. 
  • Association of Coronary Artery Calcium Score vs Age With Cardiovascular Risk in Older Adults: An Analysis of Pooled Population-Based Studies. 
  • Association of Race With Mortality and Cardiovascular Events in a Large Cohort of US Veterans. 
  • Association of angiotensinogen gene T235 variant with increased risk of coronary heart disease. 
  • Association of anxiety and depression with all-cause mortality in individuals with coronary heart disease. 
  • Association of circulating cholesteryl ester transfer protein activity with incidence of cardiovascular disease in the community. 
  • Association of depressive symptoms with reduced baroreflex cardiac control in coronary artery disease. 
  • Association of evidence-based care processes and outcomes among patients with acute coronary syndromes: performance matters. 
  • Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography. 
  • Association of low-frequency and rare coding-sequence variants with blood lipids and coronary heart disease in 56,000 whites and blacks. 
  • Association of peripheral artery disease with treatment and outcomes in acute coronary syndromes. The Global Registry of Acute Coronary Events (GRACE). 
  • Association of race with complications and prognosis following acute coronary syndromes. 
  • Association of revascularisation with low mortality in non-ST elevation acute coronary syndrome, a report from GUSTO IV-ACS. 
  • Association of statin therapy with outcomes of acute coronary syndromes: the GRACE study. 
  • Associations among social support, income, and symptoms of depression in an educated sample: the UNC Alumni Heart Study. 
  • Atorvastatin reduces the risk of cardiovascular events in patients with carotid atherosclerosis: a secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. 
  • Atypical and unusual calcifications of the heart and great vessels: imaging findings. 
  • Automated and nomographic analysis of exercise tests. 
  • Azithromycin for the secondary prevention of coronary heart disease events: the WIZARD study: a randomized controlled trial. 
  • Back to the future: improving the use of guidelines-recommended coronary disease secondary prevention at the dawn of the precision medicine era. 
  • Baseline characteristics and therapeutic goals in the New Approaches to Coronary Intervention (NACI) registry. 
  • Basic diagnostic echocardiography. 
  • Bayesian model selection and averaging in additive and proportional hazards models. 
  • Behavioral approaches to secondary prevention of coronary heart disease. 
  • Behavioral assessment of the type A behavior pattern. 
  • Behaviour and coronary artery disease: is this the missing link? 
  • Beliefs about breast cancer risk and use of postmenopausal hormone replacement therapy. 
  • Beneficial effects of pinacidil on blood lipids: comparisons with prazosin and placebo in patients with hypertension. Pinacidil-Prazosin and Pinacidil-Placebo Research Groups, Lilly Research Laboratories. 
  • Benefit of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes and troponin t-positive status: the paragon-B troponin T substudy. 
  • Benefits and drawbacks to hormone replacement therapy among nursing home patients. 
  • Benefits of coronary revascularization: a failure to communicate. 
  • Benefits of smoking cessation for longevity. 
  • Beta adrenergic and muscarinic cholinergic receptors in canine myocardium. Effects of ischemia. 
  • Better functional status in American than Canadian patients with heart disease: an effect of medical care? 
  • Biobehavioral basis of coronary-prone behavior in middle-age men. Part II: Serum cholesterol, the Type A behavior pattern, and hostility as interactive modulators of physiological reactivity. 
  • Biobehavioral basis of coronary-prone behavior in middle-aged men. Part I: Evidence for chronic SNS activation in Type As. 
  • Biomarker-Based Risk Model to Predict Cardiovascular Mortality in Patients With Stable Coronary Disease. 
  • Biosensibility of viability: NOGA or no good? 
  • Bleeding complications with platelet glycoprotein IIb/IIIa receptor antagonists. 
  • Bleeding in acute coronary syndromes. 
  • Blood pressure control and hormone replacement therapy in postmenopausal women at risk for coronary heart disease. 
  • Blood pressure reactivity to psychological stress: a new risk factor for coronary disease? 
  • Blood pressure responses to mental stress in emotionally defensive patients with stable coronary artery disease. 
  • Bridging American-Canadian health care outcome differences: is there really a gap? 
  • C-reactive protein and reclassification of cardiovascular risk in the Framingham Heart Study. 
  • C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. 
  • CASS in retrospect: lessons from the randomized cohort and registry. Coronary Artery Surgery Study. 
  • Caffeine and cholesterol: interactions with hostility. 
  • Can Mobile Health Applications Facilitate Meaningful Behavior Change?: Time for Answers. 
  • Can restenosis after coronary angioplasty be predicted from clinical variables? 
  • Canadian Consensus Conference on Coronary Thrombolysis--1994 update. 
  • Captopril and platelet-activating factor (PAF) antagonist prevent cardiac allograft vasculopathy in rats: role of endogenous PAF and PAF-like compounds. 
  • Captopril reduces graft coronary artery disease in a rat heterotopic transplant model. 
  • Carcinoid heart disease. Correlation of high serotonin levels with valvular abnormalities detected by cardiac catheterization and echocardiography. 
  • Cardiac and muscle fatigue due to relative functional overload induced by excessive stimulation, hypersensitive excitation-contraction coupling, or diminished performance capacity correlates with sarcoplasmic reticulum failure. 
  • Cardiac conduction defects in patients older than 60 years with aortic stenosis with and without mitral anular calcium. 
  • Cardiac function after restoration of flow in acute coronary occlusion. 
  • Cardiac involvement in myotonic muscular dystrophy. 
  • Cardiac rehabilitation in the elderly. 
  • Cardiac rehabilitation, exercise training, and psychosocial risk factors. 
  • Cardiac renin-angiotensin system. Molecular and functional aspects. 
  • Cardiac troponin T and cardiac troponin I: relative values in short-term risk stratification of patients with acute coronary syndromes. GUSTO-IIa Investigators. 
  • Cardiac troponins in acute coronary syndromes. 
  • Cardiac troponins in congestive heart failure. 
  • Cardiac vagal control and dynamic responses to psychological stress among patients with coronary artery disease. 
  • Cardiology and emergency medicine: united we stand, divided we fall. 
  • Cardiovascular Disease Risk Among Cancer Survivors: The Atherosclerosis Risk In Communities (ARIC) Study. 
  • Cardiovascular Disease and HIV: Pathophysiology, Treatment Considerations, and Nursing Implications. 
  • Cardiovascular and Lifestyle Risk Factors and Cognitive Function in Patients With Stable Coronary Heart Disease. 
  • Cardiovascular and emotional responses in women: the role of hostility and harassment. 
  • Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). 
  • Care of the Patient with Chest Pain in the Observation Unit. 
  • Case 2-2002. Thoracic epidural anesthesia in patients with ankylosing spondylitis undergoing coronary artery surgery. 
  • Case 6--1996, Traumatic aortocoronary saphenous vein graft occlusion. 
  • Case 6--1999. Off-pump coronary artery bypass graft surgery. 
  • Causal Effect of Plasminogen Activator Inhibitor Type 1 on Coronary Heart Disease. 
  • Cell biology and genetics of angiotensin in cardiovascular disease. 
  • Cellular and molecular mechanisms of coronary artery restenosis. 
  • Cellular electrophysiology of clofilium, a new antifibrillatory agent, in normal and ischemic canine Purkinje fibers. 
  • Cellular models of hibernating myocardium: implications for future research. 
  • Central nervous system injury associated with cardiac surgery. 
  • Central nervous system serotonin and clustering of hostility, psychosocial, metabolic, and cardiovascular endophenotypes in men. 
  • Challenges in predicting the need for coronary artery bypass grafting at presentation in patients with non-ST-segment elevation acute coronary syndromes. 
  • Challenges in the phenotypic characterisation of patients in genetic studies of coronary artery disease. 
  • Changes in patterns of coronary revascularization strategies for patients with acute coronary syndromes (from the CRUSADE Quality Improvement Initiative). 
  • Changes in plasma lipid and lipoprotein levels in men and women after a program of moderate exercise. 
  • Changes in plasma volume associated with mental stress ischemia in patients with coronary artery disease. 
  • Changing efficacy of coronary revascularization. Implications for patient selection. 
  • Characteristics and consequences of myocardial infarction after percutaneous coronary intervention: insights from the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT). 
  • Characteristics and outcome of patients in whom reperfusion with intravenous tissue-type plasminogen activator fails: results of the Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) I trial. 
  • Characteristics of socially isolated patients with coronary artery disease who are at elevated risk for mortality. 
  • Characterization of cardiovascular clinical events and impact of event adjudication on the treatment effect of darapladib versus placebo in patients with stable coronary heart disease: Insights from the STABILITY trial. 
  • Characterizing young patients with diabetes and non-ST-segment elevation acute coronary syndromes. 
  • Chest pain in the absence of coronary artery disease: a biopsychosocial perspective. 
  • Chest pain in women. 
  • Chest pain presenting as ischemic heart disease. Congenital absence of the pericardium. 
  • Chest pain self-management training for patients with coronary artery disease. 
  • Chlamydia pneumoniae and acute coronary syndrome. 
  • Cholesterol controversy--where do we go from here? 'Toward healthful diets' reevaluated. 
  • Cholesterol rethink for high-risk patients. 
  • Chronic kidney disease in patients with non-ST-segment elevation acute coronary syndromes. 
  • Clinical and Quality-of-Life Outcomes Following Invasive vs Conservative Treatment of Patients With Chronic Coronary Disease Across the Spectrum of Kidney Function. 
  • Clinical and angiographic assessment of complex mammary artery bypass grafting. 
  • Clinical and economic lessons from studies of coronary thrombolysis. 
  • Clinical and economic outcomes of liberal versus selective drug-eluting stent use: insights from temporal analysis of the multicenter Evaluation of Drug Eluting Stents and Ischemic Events (EVENT) registry. 
  • Clinical and research issues regarding chronic advanced coronary artery disease part II: Trial design, outcomes, and regulatory issues. 
  • Clinical and research issues regarding chronic advanced coronary artery disease: part I: Contemporary and emerging therapies. 
  • Clinical and therapeutic profile of patients presenting with acute coronary syndromes who do not have significant coronary artery disease.The Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) Trial Investigators. 
  • Clinical applications of antiplatelet therapy. 
  • Clinical applications of coronary sinus retroperfusion during high risk percutaneous transluminal coronary angioplasty. 
  • Clinical assessment of diastolic function. 
  • Clinical characteristics and long-term outcome of patients in whom congestive heart failure develops after thrombolytic therapy for acute myocardial infarction: development of a predictive model. 
  • Clinical characteristics and long-term survival of patients with variant angina. 
  • Clinical characteristics predict benefits from eptifibatide therapy during coronary stenting: insights from the Enhanced Suppression of the Platelet IIb/IIIa Receptor With Integrilin Therapy (ESPRIT) trial. 
  • Clinical correlates and prognostic significance of type A behavior and silent myocardial ischemia on the treadmill. 
  • Clinical correlates of the initial and long-term cost of coronary bypass surgery and coronary angioplasty. 
  • Clinical determinants of mortality in patients with angiographically diagnosed ischemic or nonischemic cardiomyopathy. 
  • Clinical end points in coronary stent trials: a case for standardized definitions. 
  • Clinical evaluation of single versus multiple mammary artery bypass. 
  • Clinical experience and predicting survival in coronary disease. 
  • Clinical implications of pulmonary hypertension in mitral stenosis. 
  • Clinical judgment and statistics. Lessons from a simulated randomized trial in coronary artery disease. 
  • Clinical outcome after coronary artery revascularization and lung transplantation. 
  • Clinical outcome of a cohort of patients eligible for therapeutic angiogenesis or transmyocardial revascularization. 
  • Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention. IMPACT-II Investigators. Integrilin (eptifibatide) to Minimize Platelet Aggregation and Coronary Thrombosis-II. 
  • Clinical pharmacology of higher dose eptifibatide in percutaneous coronary intervention (the PRIDE study). 
  • Clinical prediction models: are we building better mousetraps? 
  • Clinical relevance of C-reactive protein during follow-up of patients with acute coronary syndromes in the Aggrastat-to-Zocor Trial. 
  • Clinical significance of exercise-induced bundle branch block. 
  • Clinical significance of perfusion defects by thallium-201 single photon emission tomography following oral dipyridamole early after coronary angioplasty. 
  • Clinical success, complications and restenosis rates with excimer laser coronary angioplasty. The Percutaneous Excimer Laser Coronary Angioplasty Registry. 
  • Clinical utility of different lipid measures for prediction of coronary heart disease in men and women. 
  • Clopidogrel: the future choice for preventing platelet activation during coronary stenting? 
  • Coagulation and fibrinolytic protein kinetics in cardiopulmonary bypass. 
  • Coffee, caffeine, and cardiovascular disease. 
  • Combined TMR and mitral valve replacement via left thoracotomy. 
  • Combined exercise radionuclide angiocardiography and single photon emission computed tomography perfusion studies for assessment of coronary artery disease. 
  • Combined-modality therapy versus radiotherapy alone for treatment of early-stage Hodgkin's disease: cure balanced against complications. 
  • Commentary: This study failed? 
  • Community recruitment process by race, gender, and SES gradient: lessons learned from the Community Health and Stress Evaluation (CHASE) Study experience. 
  • Comorbidity of five chronic health conditions in elderly community residents: determinants and impact on mortality. 
  • Comparative effectiveness of revascularization strategies. 
  • Comparison of 180 degrees and 360 degrees data collection in thallium-20 1 imaging using single-photon emission computerized tomography (SPECT): concise communication. 
  • Comparison of 30-day outcome, resource use, and coronary artery disease severity in patients with suspected coronary artery disease with and without diabetes mellitus assigned to chest pain units. 
  • Comparison of Outcomes and Costs Associated With Aspirin ± Clopidogrel After Coronary Artery Bypass Grafting. 
  • Comparison of PRA-STAT, sHLA-EIA, and anti-human globulin-panel reactive antibody to identify alloreactivity in pretransplantation sera of heart transplant recipients: correlation to rejection and posttransplantation coronary artery disease. 
  • Comparison of coronary stenosis quantitation results from on-line digital and digitized cine film images. 
  • Comparison of early platelet activation in patients undergoing on-pump versus off-pump coronary artery bypass surgery. 
  • Comparison of high-dose and medium-dose propranolol in the relief of exercise-induced myocardial ischemia. 
  • Comparison of long-term (seven year) outcomes among patients undergoing percutaneous coronary revascularization with versus without stenting. 
  • Comparison of medicine alone, coronary angioplasty, and left internal mammary artery-coronary artery bypass for one-vessel proximal left anterior descending coronary artery disease. 
  • Comparison of myocardial protection with nifedipine and potassium. 
  • Comparison of one-year outcomes...ESPRIT. Enhanced Suppression of the Platelet IIb/IIIa Receptor With Integrilin Therapy. 
  • Comparison of outcome after coronary angioplasty and coronary surgery for multivessel coronary artery disease in persons with diabetes. 
  • Comparison of predictions based on observational data with the results of randomized controlled clinical trials of coronary artery bypass surgery. 
  • Comparison of risk scores for the prediction of stroke in African Americans: Findings from the Jackson Heart Study. 
  • Comparison of self-expanding and balloon-expandable stents for the reduction of restenosis. 
  • Comparison of slow oscillating versus fast balloon inflation strategies for coronary angioplasty. 
  • Comparison of survival of amiodarone-treated patients with coronary artery disease and malignant ventricular arrhythmias with that of a control group with coronary artery disease. 
  • Complementary clinical benefits of coronary-artery stenting and blockade of platelet glycoprotein IIb/IIIa receptors. Evaluation of Platelet IIb/IIIa Inhibition in Stenting Investigators. 
  • Complete and incomplete revascularization at aortocoronary bypass surgery: experience with 392 consecutive patients. 
  • Compliance with expert population-based dietary guidelines and lower odds of carotid atherosclerosis in women: the Framingham Nutrition Studies. 
  • Components of Type A, hostility, and anger-in: relationship to angiographic findings. 
  • Comprehensive Quality-of-Life Outcomes With Invasive Versus Conservative Management of Chronic Coronary Disease in ISCHEMIA. 
  • Compression of digital coronary angiograms does not affect visual or quantitative assessment of coronary artery stenosis severity. 
  • Computer-assisted ST-segment monitoring: experience during and after brief coronary occlusion. 
  • Consensus statement: cardiovascular safety profile of triptans (5-HT agonists) in the acute treatment of migraine. 
  • Consequences of reocclusion after successful reperfusion therapy in acute myocardial infarction. TAMI Study Group. 
  • Conservative management of acute coronary syndrome: cheaper and better for you? 
  • Consistency of financial interest disclosures in the biomedical literature: the case of coronary stents. 
  • Contemporary outcome trends in the elderly undergoing percutaneous coronary interventions: results in 7,472 octogenarians. National Cardiovascular Network Collaboration. 
  • Continuing evolution of therapy for coronary artery disease. Initial results from the era of coronary angioplasty. 
  • Contrast magnetic resonance imaging in the assessment of myocardial viability in patients with stable coronary artery disease and left ventricular dysfunction. 
  • Coronary angioplasty performed with gradual and prolonged inflation using a perfusion balloon catheter: procedural success and restenosis rate. 
  • Coronary arterial thrombolysis with combined infusion of recombinant tissue-type plasminogen activator and urokinase in patients with acute myocardial infarction. 
  • Coronary artery bypass grafting in patients with dialysis-dependent renal failure. 
  • Coronary artery bypass in patients with severely depressed ventricular function. 
  • Coronary artery disease and liver transplantation: the state of the art. 
  • Coronary artery disease in women: diagnosis and prevention. 
  • Coronary artery disease is associated with Alzheimer disease neuropathology in APOE4 carriers. 
  • Coronary artery disease. 
  • Coronary artery involvement in children with Kawasaki disease: risk factors from analysis of serial normalized measurements. 
  • Coronary artery stents. American College of Cardiology. 
  • Coronary bypass surgery with or without surgical ventricular reconstruction. 
  • Coronary care in New York City hospitals. 
  • Coronary heart disease in black Americans: suggestions for research on psychosocial factors. 
  • Coronary heart disease moderates the relationship of chronic stress with the metabolic syndrome. 
  • Coronary heart disease risk in patients with stroke or transient ischemic attack and no known coronary heart disease: findings from the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. 
  • Coronary intervention and glycoprotein IIb/IIIa integrin blockade. 
  • Coronary interventions "to go": Is faster better? 
  • Coronary revascularization rather than cardiac transplantation for chronic ischemic cardiomyopathy. 
  • Coronary risk associated with age and sex of parental heart disease in the Framingham Study. 
  • Correlation of adenosine echocardiography and thallium scintigraphy. 
  • Correlation of angiographic findings and right (V1 to V3) versus left (V4 to V6) precordial ST-segment depression in inferior wall acute myocardial infarction. 
  • Correlation of mitochondrial function and ischemic contracture. 
  • Cost analysis of aprotinin for coronary artery bypass patients: analysis of the randomized trials. 
  • Cost effectiveness of abciximab during routine medical practice. 
  • Cost-effectiveness of Contemporary Statin Use Guidelines With or Without Coronary Artery Calcium Assessment in African American Individuals. 
  • Cost-effectiveness of diagnostic strategies for patients with chest pain. 
  • Costs of interventional cardiac procedures. 
  • Costs of revascularization over eight years in the randomized and eligible patients in the Emory Angioplasty versus Surgery Trial (EAST). 
  • Covariation of psychological attributes and incident coronary heart disease in U.S. Air Force veterans of the Vietnam war. 
  • Creatine kinase-MB elevation after coronary artery bypass grafting surgery in patients with non-ST-segment elevation acute coronary syndromes predict worse outcomes: results from four large clinical trials. 
  • Creatine kinase-MB elevation after percutaneous coronary intervention predicts adverse outcomes in patients with acute coronary syndromes. 
  • Creation of pseudo narrowing during coronary angioplasty. 
  • Critical Appraisal of Contemporary Clinical Endpoint Definitions in Coronary Intervention Trials: A Guidance Document. 
  • Cryosurgery for cardiac arrhythmias: acute and chronic effects on coronary arteries. 
  • Culprit-only or multivessel revascularization in patients with acute coronary syndromes: an American College of Cardiology National Cardiovascular Database Registry report. 
  • Current knowledge of the platelet glycoprotein IIb/IIIa receptor antagonists for the treatment of coronary artery disease. 
  • Current management of mitral valve incompetence associated with coronary artery disease. 
  • Current multicentre studies with the excimer laser: design and aims. 
  • Current prognosis of ischemic mitral regurgitation. Implications for future management. 
  • Current status of biodegradable stents. 
  • Cynicism and paranoid alienation in the Cook and Medley HO Scale. 
  • Cytokine genotypes in kidney, heart, and lung recipients: consequences for acute and chronic rejection. 
  • Darapladib for preventing ischemic events in stable coronary heart disease. 
  • Day-by-Day Variability of Home Blood Pressure and Incident Cardiovascular Disease in Clinical Practice: The J-HOP Study (Japan Morning Surge-Home Blood Pressure). 
  • Dealing with the highs and lows of contrast agents in left main disease. 
  • Demonstration of a relation between urinary digoxin-like immunoreactive substance and cardiac performance. 
  • Deployment of a previously embolized, unexpanded, and disarticulated Palmaz-Schatz stent. 
  • Depression and cardiac risk. 
  • Depression and coronary heart disease: recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Psychiatric Association. 
  • Depression and heart disease: evidence of a link, and its therapeutic implications. 
  • Depression and long-term mortality risk in patients with coronary artery disease. 
  • Depression as a risk factor for coronary artery disease: evidence, mechanisms, and treatment. 
  • Depression as risk factor for mortality after coronary artery bypass surgery. 
  • Depression in male and female patients undergoing cardiac surgery. 
  • Depression in patients with coronary artery disease. 
  • Depressive Symptoms and Risk of Cardiovascular Events in Blacks: Findings From the Jackson Heart Study. 
  • Depressive symptoms and mental stress-induced myocardial ischemia in patients with coronary heart disease. 
  • Depressive symptoms and outcome of coronary artery bypass grafting. 
  • Depressive symptoms and survival of patients with coronary artery disease. 
  • Design and methodology of the ESPRIT trial: evaluating a novel dosing regimen of eptifibatide in percutaneous coronary intervention. 
  • Design of the Genetics of Early Onset Cardiovascular Disease (GENECARD) study. 
  • Designing and implementing a comparative effectiveness study of two strategies for delivering high quality CHD prevention: methods and participant characteristics for the Heart to Health study. 
  • Detection of restenosis after elective percutaneous transluminal coronary angioplasty using the exercise treadmill test. 
  • Detection of silent myocardial ischemia in diabetes mellitus. 
  • Deterioration of regional wall motion immediately after coronary artery bypass graft surgery is associated with long-term major adverse cardiac events. 
  • Determinants of 15-year outcome with 1,119 standard Carpentier-Edwards porcine valves. 
  • Determinants of early versus late cardiac death in patients undergoing coronary artery bypass graft surgery. 
  • Determinants of thrombin generation, fibrinolytic activity, and endothelial dysfunction in patients on dual antiplatelet therapy: involvement of factors other than platelet aggregability in Virchow's triad. 
  • Determination of the falloff constant (k(f)) from modeling biochemical marker release: a new variable for discriminating therapies. 
  • Development and validation of a simple model to predict severe coronary artery disease after myocardial infarction: potential impact on cardiac catheterization use in the United States and Canada. 
  • Development of a brief self-report measure of the type A (coronary prone) behavior pattern. 
  • Development of a new technique for reducing pressure pulse generation during 308-nm excimer laser coronary angioplasty. 
  • Development of systems of care for ST-elevation myocardial infarction patients: the primary percutaneous coronary intervention (ST-elevation myocardial infarction-receiving) hospital perspective. 
  • Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. 
  • Diabetic atrial fibrillation patients: mortality and risk for stroke or embolism during a 10-year follow-up. 
  • Diabetic retinopathy and the risk of coronary heart disease: the Atherosclerosis Risk in Communities Study. 
  • Diagnosing coronary arterial stent thrombosis and arterial closure. 
  • Diagnosis, incidence, and clinical significance of early postoperative ischemia after transmyocardial laser revascularization. 
  • Diagnostic and prognostic significance of exercise-induced premature ventricular complexes in men and women: a four year follow-up. 
  • Diagnostic test use in different practice settings. A controlled comparison. 
  • Dialysis Initiation in Patients With Chronic Coronary Disease and Advanced Chronic Kidney Disease in ISCHEMIA-CKD. 
  • Diet and secondary prevention of coronary disease: is it time to stop chewing the fat? 
  • Dietary patterns and the risk of major adverse cardiovascular events in a global study of high-risk patients with stable coronary heart disease. 
  • Differences among the parenteral platelet glycoprotein IIb/IIIa inhibitors and implications for treatment. 
  • Differences between local hospital and core laboratory interpretation of the admission electrocardiogram in patients with acute coronary syndromes and their relation to outcome. 
  • Differences in Metabolomic Profiles Between Black and White Women and Risk of Coronary Heart Disease: an Observational Study of Women From Four US Cohorts. 
  • Differences in baseline characteristics and in-hospital outcomes in patients with or without prior stroke undergoing percutaneous coronary intervention. 
  • Differences in inducibility and prognosis of in-hospital versus out-of-hospital identified nonsustained ventricular tachycardia in patients with coronary artery disease: clinical and trial design implications. 
  • Different effects of two types of ischemia on myocardial systolic and diastolic function. 
  • Differential effects of antihypertensive agents in experimental and human atherosclerosis. 
  • Differential treatment benefit of platelet glycoprotein IIb/IIIa inhibition with percutaneous coronary intervention versus medical therapy for acute coronary syndromes: exploration of methods. 
  • Differential ventricular ischemic injury: an experimental model of right ventricular failure with a variable degree of left ventricular dysfunction. 
  • Digital subtraction angiography in angioplasty of total coronary artery occlusion. 
  • Diltiazem preserves direct vasodilator response but fails to suppress intimal proliferation in rat allograft coronary artery disease. 
  • Dipyridamole myocardial SPECT with low heart rate response indicates cardiac autonomic dysfunction in patients with diabetes. 
  • Direct myocardial revascularization and angiogenesis--how many patients might be eligible? 
  • Direct thrombin inhibitors in acute coronary syndromes: effect in patients undergoing early percutaneous coronary intervention. 
  • Discordance of databases designed for claims payment versus clinical information systems. Implications for outcomes research. 
  • Discordant cardiac biomarkers: frequency and outcomes in emergency department patients with chest pain. 
  • Discriminant function analysis using thallium-201 scintiscans and exercise stress variables to predict coronary heart disease. 
  • Discriminating clinical features of heart failure with preserved vs. reduced ejection fraction in the community. 
  • Disruption of myofibrillar energy use: dual mechanisms that may contribute to postischemic dysfunction in stunned myocardium. 
  • Dissociation between early recovery of regional function and purine nucleotide content in postischaemic myocardium in the conscious dog. 
  • Dissociation between global and regional systolic and diastolic ventricular function during coronary occlusion and reperfusion. 
  • Dissociation of ST segment elevation and regional wall motion with open-artery, intracoronary Fluosol. 
  • Dissociation of the prostaglandin and renin angiotensin systems during captopril therapy for chronic congestive heart failure secondary to coronary artery disease. 
  • Do benzodiazepines have a role in the prevention or treatment of coronary heart disease and other major medical disorders? 
  • Do healthy adults need to know their cholesterol level? 
  • Dobutamine stress echocardiography for preoperative cardiac risk stratification in patients undergoing orthotopic liver transplantation. 
  • Dobutamine stress echocardiography: experience in pediatric heart transplant recipients. 
  • Does ambulatory monitoring contribute to exercise testing and myocardial perfusion scintigraphy in the prediction of the extent of coronary artery disease in stable angina? 
  • Does anesthetic technique make a difference? Augmentation of systolic blood pressure during carotid endarterectomy: effects of phenylephrine versus light anesthesia and of isoflurane versus halothane on the incidence of myocardial ischemia. 
  • Does chronic Chlamydia pneumoniae infection increase the risk of myocardial injury? Insights from patients with non-ST-elevation acute coronary syndromes. 
  • Does coronary surgery prolong life in comparison with medical management? 
  • Does hypotension during dobutamine stress echocardiography correlate with anatomic or functional cardiac impairment? 
  • Does the discharge ECG provide additional prognostic insight(s) in non-ST elevation ACS patients from that acquired on admission? 
  • Does the electrocardiographic pattern of "anteroseptal" myocardial infarction correlate with the anatomic location of myocardial injury? 
  • Does the presence of coronary artery disease impact perioperative outcomes following partial hepatectomy? 
  • Dose-finding, safety, and tolerability study of an oral platelet glycoprotein IIb/IIIa inhibitor, lotrafiban, in patients with coronary or cerebral atherosclerotic disease. 
  • Dosing and administration of ReoPro (c7E3 Fab). 
  • Double negatives. 
  • Durability of platelet inhibition by clopidogrel. 
  • Dynamic mechanisms of cardiac oxygenation during brief ischemia and reperfusion. 
  • ECG subanalyses in clinical trials: an investigator's perspective. 
  • EDTA chelation therapy alone and in combination with oral high-dose multivitamins and minerals for coronary disease: The factorial group results of the Trial to Assess Chelation Therapy. 
  • ESC Forum on Drug Eluting Stents European Heart House, Nice, 27-28 September 2007. 
  • Early invasive strategy for acute coronary syndromes without persistent ST-segment elevation: has the time come for 'drive-through' angiography? 
  • Early mortality of acute myocardial infarction in patients with and without prior coronary revascularization surgery. A Coronary Artery Surgery Study Registry Study. 
  • Early use of glycoprotein IIb/IIIa inhibitors in the ED treatment of non-ST-segment elevation acute coronary syndromes: a local quality improvement initiative. 
  • Echocardiographic visualization of coronary artery anatomy in the adult. 
  • Echocardiography for the assessment of myocardial viability. 
  • Economic Outcomes With Anatomical Versus Functional Diagnostic Testing for Coronary Artery Disease. 
  • Economic assessment of low-molecular-weight heparin (enoxaparin) versus unfractionated heparin in acute coronary syndrome patients: results from the ESSENCE randomized trial. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q wave Coronary Events [unstable angina or non-Q-wave myocardial infarction]. 
  • Economic impact of GPIIB/IIIA blockade after high-risk angioplasty: results from the RESTORE trial. Randomized Efficacy Study of Tirofiban for Outcomes and Restenosis. 
  • Economic impact of drug-eluting stents on hospital systems: a disease-state model. 
  • Economic impact of new interventional therapies: are we asking the right questions? 
  • Economic winners and losers after introduction of an effective new therapy depend on the type of payment system. 
  • Economics methods in the Clinical Outcomes Utilizing percutaneous coronary Revascularization and Aggressive Guideline-driven drug Evaluation (COURAGE) trial. 
  • Effect of Exercise, Escitalopram, or Placebo on Anxiety in Patients With Coronary Heart Disease: The Understanding the Benefits of Exercise and Escitalopram in Anxious Patients With Coronary Heart Disease (UNWIND) Randomized Clinical Trial. 
  • Effect of Type A behavior on exercise test outcome in coronary artery disease. 
  • Effect of alpha-adrenergic stimulation on regional contractile function and myocardial blood flow with and without ischemia. 
  • Effect of atorvastatin in elderly patients with a recent stroke or transient ischemic attack. 
  • Effect of cardiac rehabilitation on functional outcomes after coronary revascularization. 
  • Effect of coronary artery bypass graft surgery on survival. 
  • Effect of eptifibatide for acute coronary syndromes: rapid versus late administration--therapeutic yield on platelets (The EARLY Platelet Substudy). 
  • Effect of eptifibatide on coronary flow reserve following coronary stent implantation (an ESPRIT substudy). Enhanced Suppression of the Platelet IIb/IIIa Receptor with Integrilin Therapy. 
  • Effect of escitalopram on mental stress-induced myocardial ischemia: results of the REMIT trial. 
  • Effect of gastric bypass operation on Framingham and actual risk of cardiovascular events in class II to III obesity. 
  • Effect of glycoprotein IIb/IIIa receptor inhibition on angiographic complications during percutaneous coronary intervention in the ESPRIT trial. 
  • Effect of selective serotonin reuptake inhibitors on platelets in patients with coronary artery disease. 
  • Effect of smoking and sedentary behavior on the association between depressive symptoms and mortality from coronary heart disease. 
  • Effect of variability in the interpretation of coronary angiograms on the appropriateness of use of coronary revascularization procedures. 
  • Effectiveness of revascularization in the Emory angioplasty versus surgery trial. A randomized comparison of coronary angioplasty with bypass surgery. 
  • Effects of 308 nanometer excimer laser energy on 316 L stainless-steel stents: implications for laser atherectomy of in-stent restenosis. 
  • Effects of Acute Exercise on Anxiety Ratings in Patients With Coronary Heart Disease and Elevated Anxiety. 
  • Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease. 
  • Effects of Exercise and Sertraline on Measures of Coronary Heart Disease Risk in Patients With Major Depression: Results From the SMILE-II Randomized Clinical Trial. 
  • Effects of a single intracoronary injection of basic fibroblast growth factor in stable angina pectoris. 
  • Effects of admission to a teaching hospital on the cost and quality of care for Medicare beneficiaries. 
  • Effects of age and gender on the relationship between anxiety and coronary artery disease. 
  • Effects of atrial fibrillation on myocardial blood flow in the ischemic heart of the dog. 
  • Effects of chronic systemic administration of basic fibroblast growth factor on collateral development in the canine heart. 
  • Effects of coronary angioplasty, coronary bypass surgery, and medical therapy on employment in patients with coronary artery disease. A prospective comparison study. 
  • Effects of decreased preoperative endotoxin core antibody levels on long-term mortality after coronary artery bypass graft surgery. 
  • Effects of delay in administration of potassium cardioplegia to the isolated rat heart. 
  • Effects of dependency among causes of death for cause elimination life table strategies. 
  • Effects of exercise and stress management training on nighttime blood pressure dipping in patients with coronary heart disease: A randomized, controlled trial. 
  • Effects of exercise on the Type A (coronary prone) behavior pattern. 
  • Effects of hemoperfusion during percutaneous transluminal coronary angioplasty on left ventricular function. 
  • Effects of mental stress on myocardial ischemia during daily life. 
  • Effects of physical conditioning on left ventricular ejection fraction in patients with coronary artery disease. 
  • Effects of propranolol on the hemodynamic, coronary sinus blood flow and myocardial metabolic response to atrial pacing. 
  • Effects of roxifiban on platelet aggregation and major receptor expression in patients with coronary artery disease for the Roxifiban Oral Compound Kinetics Evaluation Trial-I (ROCKET-I Platelet Substudy). 
  • Effects of task incentive on cardiovascular response in type A and type B individuals. 
  • Effects on blood lipids of a blood pressure-lowering diet: the Dietary Approaches to Stop Hypertension (DASH) Trial. 
  • Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials. 
  • Efficacy and safety of enoxaparin compared with unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention in the Superior Yield of the New Strategy of Enoxaparin, Revascularization and Glycoprotein IIb/IIIa Inhibitors (SYNERGY) trial. 
  • Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. 
  • Efficacy of abciximab readministration in coronary intervention. 
  • Efficacy of azimilide for the maintenance of sinus rhythm in patients with paroxysmal atrial fibrillation in the presence and absence of structural heart disease. 
  • Efficacy of the internal mammary artery in combined aortic valve replacement-coronary artery bypass grafting. 
  • Egg Consumption and Risk of Total and Cause-Specific Mortality: An Individual-Based Cohort Study and Pooling Prospective Studies on Behalf of the Lipid and Blood Pressure Meta-analysis Collaboration (LBPMC) Group. 
  • Eight-year follow-up of exercise electrocardiograms in healthy, middle-aged aviators. 
  • Eight-year mortality in the Emory Angioplasty versus Surgery Trial (EAST). 
  • Ejection fraction response to exercise in patients with chest pain, coronary artery disease and normal resting ventricular function. 
  • Elective percutaneous coronary intervention using broad-spectrum antiplatelet therapy (eptifibatide, clopidogrel, and aspirin) alone, without scheduled unfractionated heparin or other antithrombin therapy. 
  • Electrocardiographic J Wave and Cardiovascular Outcomes in the General Population (from the Atherosclerosis Risk In Communities Study). 
  • Electrocardiographic monitoring and coronary occlusion. Fingerprint pattern analysis in dimensions of space, time, and mind. 
  • Electron beam computed tomography: on its way into mainstream cardiology? 
  • Electron-beam computed tomography in the assessment of coronary artery disease after heart transplantation. 
  • Electrophysiologic testing to identify patients at risk for sudden death. 
  • Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. Multicenter Unsustained Tachycardia Trial Investigators. 
  • Elevated uric acid levels predict allograft vasculopathy in cardiac transplant recipients. 
  • Emergency Department education improves patient knowledge of coronary artery disease risk factors but not the accuracy of their own risk perception. 
  • Emerging treatment of acute coronary syndromes with platelet glycoprotein IIB/IIIA inhibitors. 
  • Emory Angioplasty Versus Surgery Trial (EAST): design, recruitment, and baseline description of patients. 
  • Emotional responsivity and transient myocardial ischemia. 
  • Encircling endocardial ventriculotomy for refractory ischemic ventricular tachycardia. I. Electrophysiological effects. 
  • Encircling endocardial ventriculotomy for refractory ischemic ventricular tachycardia. II. Effects on regional myocardial blood flow. 
  • Encircling endocardial ventriculotomy for refractory ischemic ventricular tachycardia. III. Effects on regional left ventricular function. 
  • Endoscopic versus open vein-graft harvesting in coronary-artery bypass surgery. 
  • Enhanced efficacy of eptifibatide administration in patients with acute coronary syndrome requiring in-hospital coronary artery bypass grafting. PURSUIT Investigators. 
  • Enhanced platelet/endothelial activation in depressed patients with acute coronary syndromes: evidence from recent clinical trials. 
  • Enhancing Cardiac Rehabilitation With Stress Management Training: A Randomized, Clinical Efficacy Trial. 
  • Enhancing Recovery in Coronary Heart Disease (ENRICHD) study intervention: rationale and design. 
  • Enhancing recovery in coronary heart disease patients (ENRICHD): study design and methods. The ENRICHD investigators. 
  • Enoxaparin dosing and associated risk of in-hospital bleeding and death in patients with non ST-segment elevation acute coronary syndromes. 
  • Enoxaparin versus unfractionated heparin in patients treated with tirofiban, aspirin and an early conservative initial management strategy: results from the A phase of the A-to-Z trial. 
  • Epidemiology and risk factors for heart failure in the elderly. 
  • Eptifibatide in coronary intervention: past time for the next chapter. 
  • Eptifibatide in percutaneous coronary intervention. A review. 
  • Eptifibatide: a potent inhibitor of the platelet receptor integrin glycoprotein IIb/IIIa. 
  • Equivalence of improvement in area under ROC curve and linear discriminant analysis coefficient under assumption of normality. 
  • Ergonovine maleate testing during cardiac catheterization: a 10-year perspective in 3,447 patients without significant coronary artery disease or Prinzmetal's variant angina. 
  • Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data. 
  • Estimates of U.S. multiple cause life tables. 
  • Estimating the likelihood of severe coronary artery disease. 
  • Estimating the likelihood of significant coronary artery disease. 
  • Ethics and equipoise: rationale for a placebo-controlled study design of platelet glycoprotein IIb/IIIa inhibition in coronary intervention. 
  • Ethnic differences in the treatment of depression in patients with ischemic heart disease. 
  • Etiology and differential diagnosis of acute mitral regurgitation. 
  • Evaluating the exposure and disease relationship with adjustment for different types of exposure misclassification: a regression approach. 
  • Evaluating the potential 'economic attractiveness' of new therapies in patients with non-ST elevation acute coronary syndrome. 
  • Evaluation and management of thrombocytopenia and suspected heparin-induced thrombocytopenia in hospitalized patients: The Complications After Thrombocytopenia Caused by Heparin (CATCH) registry. 
  • Evaluation of a QRS scoring system for estimating myocardial infarct size. III. Correlation with quantitative anatomic findings for inferior infarcts. 
  • Evaluation of a coronary-cameral fistula: benefits of coronary dual-source MDCT angiography in children. 
  • Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study. 
  • Evaluation of dyslipidemia in the emergency department: impact of cholesterol testing on subsequent therapy. 
  • Evaluation of the Framingham risk score in the European Prospective Investigation of Cancer-Norfolk cohort--invited commentary. 
  • Evaluation of the National Cholesterol Education Program Adult Treatment Panel III algorithm for selecting candidates for statin therapy: insights from the A to Z trial. 
  • Evaluation of the QRS complex on the standard 12-lead electrocardiogram in normal subjects 70 to 79 years of age. 
  • Evaluation of the left ventricle with two dimensional echocardiography. 
  • Events leading to the treatment of coronary artery disease: implications for nursing care. 
  • Evidence for a black-white crossover in all-cause and coronary heart disease mortality in an older population: the North Carolina EPESE. 
  • Evidence for substantial effect modification by gender in a large-scale genetic association study of the metabolic syndrome among coronary heart disease patients. 
  • Evidence supporting secondary prevention strategies. 
  • Evolution of the coronary care unit: clinical characteristics and temporal trends in healthcare delivery and outcomes. 
  • Evolving trends in interventional device use and outcomes: results from the National Cardiovascular Network Database. 
  • Examining the heterogeneity inexcess risks of coronary heart disease, stroke, dialysis, and lower extremity amputation associated with type 2 diabetes mellitus across demographic subgroups in an Asian population: A population-based matched cohort study. 
  • Excess body mass index- and waist circumference-years and incident cardiovascular disease: the CARDIA study. 
  • Excimer laser coronary angioplasty: the New Approaches to Coronary Intervention (NACI) experience. 
  • Exercise and atherosclerotic heart disease in women. 
  • Exercise and pharmacological treatment of depressive symptoms in patients with coronary heart disease: results from the UPBEAT (Understanding the Prognostic Benefits of Exercise and Antidepressant Therapy) study. 
  • Exercise echocardiography or exercise SPECT imaging? A meta-analysis of diagnostic test performance. 
  • Exercise echocardiography vs exercise SPECT testing. 
  • Exercise radionuclide angiocardiography predicts cardiac death in patients with coronary artery disease. 
  • Exercise stress testing in evaluation of aortocoronary bypass surgery. Report of 123 patients. 
  • Exercise training in healthy type A middle-aged men: effects on behavioral and cardiovascular responses. 
  • Exercise training of patients with ventricular dysfunction and heart failure. 
  • Exercise treadmill score for predicting prognosis in coronary artery disease. 
  • Exogenous exposures shape genetic predisposition to lipids, Alzheimer's, and coronary heart disease in the MLXIPL gene locus. 
  • Expected and realized benefits from coronary bypass surgery in relation to severity of illness. 
  • Extended-release niacin vs gemfibrozil for the treatment of low levels of high-density lipoprotein cholesterol. Niaspan-Gemfibrozil Study Group. 
  • Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. 
  • Extent of coronary artery disease as a predictor of outcomes in acute myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. 
  • Facial expression and the affective component of cynical hostility in male coronary heart disease patients. 
  • Factors affecting sensitivity and specificity of exercise electrocardiography. Multivariable analysis. 
  • Failure of adjuvant heparin to reduce myocardial ischemia in the early treatment of patients with unstable angina. 
  • Failure of normalized ventricular filling rates to predict true filling rates. 
  • Fibrinogen may mediate the association between long sleep duration and coronary heart disease. 
  • First clinical application of an actively reversible direct factor IXa inhibitor as an anticoagulation strategy in patients undergoing percutaneous coronary intervention. 
  • First experience with direct factor Xa inhibition in patients with stable coronary disease: a pharmacokinetic and pharmacodynamic evaluation. 
  • First-degree AV block-an entirely benign finding or a potentially curable cause of cardiac disease? 
  • Fixing the heart: must the brain pay the price? 
  • Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. 
  • Formation of myocardial zonal lesions. 
  • Fractal analysis of retinal microvasculature and coronary heart disease mortality. 
  • Frequency and Predictors of Internal Mammary Artery Graft Failure and Subsequent Clinical Outcomes: Insights From the Project of Ex-vivo Vein Graft Engineering via Transfection (PREVENT) IV Trial. 
  • Frequency and consequences of recording an electrocardiogram >10 minutes after arrival in an emergency room in non-ST-segment elevation acute coronary syndromes (from the CRUSADE Initiative). 
  • Frequency of low serum high-density lipoprotein cholesterol levels in hospitalized patients with "desirable" total cholesterol levels. 
  • Frequency of stent thrombosis after acute coronary syndromes (from the SYMPHONY and 2nd SYMPHONY trials). 
  • Frequency of transient reductions in left ventricular ejection fraction at rest in coronary artery disease. 
  • From HIRMIT to the Cape May Lighthouse. Revascularization reconsidered in very high risk patients at the Duke Heart Center. 
  • Fusigenic viral liposome for gene therapy in cardiovascular diseases. 
  • Gating provides improved accuracy for differentiating artifacts from true lesions in equivocal fixed defects on technetium 99m tetrofosmin perfusion SPECT. 
  • Gender and heart disease. 
  • Gender disparities in the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: large-scale observations from the CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the American College of Cardiology/American Heart Association Guidelines) National Quality Improvement Initiative. 
  • Gender, cardiology, and optimal medical care. 
  • Gene by sex interaction in the etiology of coronary heart disease and the preceding metabolic syndrome. 
  • Gene therapy for human bypass grafts. 
  • Genetic approaches for the investigation of genes associated with coronary heart disease. 
  • Genetic influences on CHD-death and the impact of known risk factors: comparison of two frailty models. 
  • Genetic variation in heat shock protein 60 gene and coronary heart disease in China: tagging-SNP haplotype analysis in a case-control study. 
  • Genetics of coronary heart disease: current knowledge and research principles. 
  • Genetics of coronary heart disease: current understanding and future prospects. 
  • Genome-wide association of pericardial fat identifies a unique locus for ectopic fat. 
  • Genome-wide association study of coronary heart disease and its risk factors in 8,090 African Americans: the NHLBI CARe Project. 
  • Global risk of coronary heart disease: assessment and application. 
  • Glycated hemoglobin measurement and prediction of cardiovascular disease. 
  • Glycoprotein IIb-IIIa inhibition with abciximab and postprocedural risk assessment: lessons from the evaluation of platelet IIb/IIIa inhibitor for stenting trial and implication for ad hoc use of glycoprotein IIb-IIIa antagonists. 
  • Glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: pathophysiologic foundation and clinical findings. 
  • Glycoprotein IIb/IIIa integrin blockade. 
  • Glycoprotein IIb/IIIa receptor antagonists in non-ST elevation acute coronary syndromes and percutaneous revascularisation: a review of trial reports. 
  • Graded exercise stress tests in angiographically documented coronary artery disease. 
  • Graft vascular disease after cardiac transplantation and its relationship to mean acute rejection score. 
  • Graphical assessment of incremental value of novel markers in prediction models: From statistical to decision analytical perspectives. 
  • Guidelines for carotid endarterectomy. A multidisciplinary consensus statement from the Ad Hoc Committee, American Heart Association. 
  • Guidelines for carotid endarterectomy. A multidisciplinary consensus statement from the ad hoc Committee, American Heart Association. 
  • Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. 
  • Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. 
  • HIV and cardiovascular disease in sub-Saharan Africa: the Sutton Law as applied to global health. 
  • Health Status and Clinical Outcomes in Older Adults With Chronic Coronary Disease: The ISCHEMIA Trial. 
  • Health-Status Outcomes with Invasive or Conservative Care in Coronary Disease. 
  • Heart disease epidemic in Pakistan: women and men at equal risk. 
  • Heart failure with preserved left ventricular systolic function among patients with non-ST-segment elevation acute coronary syndromes. 
  • Heart sound simulation: how useful for critical care nurses? 
  • Hemodynamic correlates for timing intervals, ejection rate and filling rate derived from the radionuclide angiographic volume curve. 
  • Hemodynamic effects of synchronized high-frequency jet ventilation compared with low-frequency intermittent positive-pressure ventilation after myocardial revascularization. 
  • Hemodynamic evaluation of glucagon in symptomatic heart disease. 
  • Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety. 
  • Heparin dosing and outcome in acute coronary syndromes: the GUSTO-IIb experience. Global Use of Strategies to Open Occluded Coronary Arteries. 
  • Heritability of death from coronary heart disease: a 36-year follow-up of 20 966 Swedish twins. 
  • Heterogeneity of the Predictive Polygenic Risk Scores for Coronary Heart Disease Age-at-Onset in Three Different Coronary Heart Disease Family-Based Ascertainments. 
  • High risk percutaneous coronary intervention and intra-aortic balloon pumps: when is the safety net needed? 
  • High-dose aprotinin effectively reduces blood loss during on-pump coronary artery bypass grafting with bivalirudin anticoagulation. 
  • Highlights from the American Heart Association annual scientific sessions 2001: November 11 to 14, 2001. 
  • Home surveillance program prevents interstage mortality after the Norwood procedure. 
  • Hospital visitors as controls. 
  • Hostility as a predictor of survival in patients with coronary artery disease. 
  • Hostility during late adolescence predicts coronary risk factors at mid-life. 
  • Hostility in asymptomatic men with angiographically confirmed coronary artery disease. 
  • Hostility, CHD incidence, and total mortality: a 25-year follow-up study of 255 physicians. 
  • Hostility, coronary risk, and alpha-adrenergic to beta-adrenergic receptor density ratio. 
  • How best to monitor for detection of myocardial ischemia? 
  • Hydrops fetalis associated with idiopathic arterial calcification. 
  • Hypercholesterolemia is common after pediatric heart transplantation: initial experience with pravastatin. 
  • Hyperlipidemia and transplantation: etiologic factors and therapy. 
  • Hyperlipidemia in early adulthood increases long-term risk of coronary heart disease. 
  • Hypertensive retinopathy and incident coronary heart disease in high risk men. 
  • ISCHEMIA-EXTEND studies: Rationale and design. 
  • Identification of chest pain patients appropriate for an emergency department observation unit. 
  • Identification of high-risk patients with silent myocardial ischemia after percutaneous transluminal coronary angioplasty by multilead monitoring. 
  • Identification of patients with coronary disease at high risk for loss of employment. A prospective validation study. 
  • Identification of the optimal electrocardiographic leads for detecting acute epicardial injury in acute myocardial infarction. 
  • Images in cardiology. Coronary artery calcification. 
  • Immediate and reversible platelet inhibition after intravenous administration of a peptide glycoprotein IIb/IIIa inhibitor during percutaneous coronary intervention. 
  • Immediate hemodynamic effects of acute coronary occlusion and their modification by anesthesia. 
  • Impact of bleeding severity on clinical outcomes among patients with acute coronary syndromes. 
  • Impact of combat deployment and posttraumatic stress disorder on newly reported coronary heart disease among US active duty and reserve forces. 
  • Impact of comorbidities on ischemic stroke outcomes in women. 
  • Impact of congestive heart failure in patients with non-ST-segment elevation acute coronary syndromes. 
  • Impact of diabetes on the risk stratification using stress single-photon emission computed tomography myocardial perfusion imaging in patients with symptoms suggestive of coronary artery disease. 
  • Impact of ethnicity and gender differences on angiographic coronary artery disease prevalence and in-hospital mortality in the American College of Cardiology-National Cardiovascular Data Registry. 
  • Impact of extracardiac vascular disease on vein graft failure and outcomes after coronary artery bypass surgery. 
  • Impact of home warfarin use on the treatment and outcomes of patients undergoing percutaneous coronary intervention. 
  • Impact of impaired fasting glucose on cardiovascular disease: the Framingham Heart Study. 
  • Impact of inflammatory biomarkers on relation of high density lipoprotein-cholesterol with incident coronary heart disease: cardiovascular Health Study. 
  • Impact of intensive lipid modulation on angiographically defined coronary disease: clinical implications. 
  • Impact of left ventricular dysfunction on hospital mortality among patients undergoing elective percutaneous coronary intervention. 
  • Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY Trial. 
  • Impact of mitral valve regurgitation evaluated by intraoperative transesophageal echocardiography on long-term outcomes after coronary artery bypass grafting. 
  • Impact of multivessel disease on reperfusion success and clinical outcomes in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction. 
  • Impact of on-site cardiac interventional facilities on management and outcome of patients with acute coronary syndromes. 
  • Impact of preoperative renal dysfunction in patients undergoing off-pump versus on-pump coronary artery bypass. 
  • Impact of preprocedural white blood cell count on long term mortality after percutaneous coronary intervention: insights from the EPIC, EPILOG, and EPISTENT trials. 
  • Impact of renal dysfunction on outcomes of coronary artery bypass surgery: results from the Society of Thoracic Surgeons National Adult Cardiac Database. 
  • Impaired endothelial function in coronary heart disease patients with depressive symptomatology. 
  • Implications of Abnormal Exercise Electrocardiography With Normal Stress Echocardiography. 
  • Implications of cost in treatment selection for patients with coronary heart disease. 
  • Importance of baseline functional and socioeconomic factors for participation in cardiac rehabilitation. 
  • Importance of clinical measures of ischemia in the prognosis of patients with documented coronary artery disease. 
  • Improved survival of surgically treated patients with triple vessel coronary artery disease and severe angina pectoris. A report from the Coronary Artery Surgery Study (CASS) registry. 
  • Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. 
  • Improving Medication Adherence in Coronary Heart Disease. 
  • In patients with stable coronary heart disease, low-density lipoprotein-cholesterol levels < 70 mg/dL and glycosylated hemoglobin A1c < 7% are associated with lower major cardiovascular events. 
  • In-hospital mortality associated with the use of intra-aortic balloon counterpulsation. 
  • In-hospital outcomes of percutaneous coronary interventions in extremely obese and normal-weight patients: findings from the NCDR (National Cardiovascular Data Registry). 
  • In-stent pseudo-restenosis due to an organized thrombus six months after implantation of a sirolimus-eluting stent. 
  • Incidence and clinical significance of cardiac biomarker elevation during stem cell mobilization, apheresis, and intramyocardial delivery: an analysis from ACT34-CMI. 
  • Incidence and long-term significance of transient ST segment deviation in hemodialysis patients. 
  • Incidence of caffeine in serum of patients undergoing dipyridamole myocardial perfusion stress test by an intensive versus routine caffeine history screening. 
  • Incidence of dyspnea and assessment of cardiac and pulmonary function in patients with stable coronary artery disease receiving ticagrelor, clopidogrel, or placebo in the ONSET/OFFSET study. 
  • Incomplete relaxation between beats after myocardial hypoxia and ischemia. 
  • Increased body mass index is a risk factor for end-stage renal disease in the Chinese Singapore population. 
  • Increased soluble platelet/endothelial cellular adhesion molecule-1 and osteonectin levels in patients with severe congestive heart failure. Independence of disease etiology, and antecedent aspirin therapy. 
  • Incremental prognostic value of RNA ejection fraction measurements during pharmacologic stress testing: a comparison with clinical and perfusion variables. 
  • Incremental value of the exercise test for diagnosing the presence or absence of coronary artery disease. 
  • Inflammatory mechanisms. 
  • Influence of clinical trial enrollment on the quality of care and outcomes for patients with non-ST-segment elevation acute coronary syndromes. 
  • Influence of depression and effect of treatment with sertraline on quality of life after hospitalization for acute coronary syndrome. 
  • Influence of imprecision on ROC curve analysis for cardiac markers. 
  • Influence of racial disparities in procedure use on functional status outcomes among patients with coronary artery disease. 
  • Informational Quest. 
  • Initial Invasive or Conservative Strategy for Stable Coronary Disease. 
  • Initial experience with an intravenous P2Y12 platelet receptor antagonist in patients undergoing percutaneous coronary intervention: results from a 2-part, phase II, multicenter, randomized, placebo- and active-controlled trial. 
  • Initial functional and economic status of patients with multivessel coronary artery disease randomized in the Bypass Angioplasty Revascularization Investigation (BARI). 
  • Initial platelet activity may predict efficacy after chronic oral glycoprotein IIb/IIIa blockade: should we still consider uniform treatment regimens? 
  • Insights derived from the thrombolysis and angioplasty in myocardial infarction (TAMI) trials. 
  • Insomnia and heart disease: a review of epidemiologic studies. 
  • Insulin resistance independently predicts the progression of coronary artery calcification. 
  • Insurance coverage and care of patients with non-ST-segment elevation acute coronary syndromes. 
  • Integrative noetic therapies as adjuncts to percutaneous intervention during unstable coronary syndromes: Monitoring and Actualization of Noetic Training (MANTRA) feasibility pilot. 
  • Interactions between heparins, glycoprotein IIb/IIIa antagonists, and coronary intervention. The Global Registry of Acute Coronary Events (GRACE). 
  • Interchangeability of activated clotting time values across different point-of-care systems. 
  • Interinstitutional variation in the use of abciximab for percutaneous coronary intervention. 
  • International variation in invasive care of the elderly with acute coronary syndromes. 
  • International variation in the use of evidence-based medicines for acute coronary syndromes. 
  • Interpersonal Hostility Assessment Technique: description and validation against the criterion of coronary artery disease. 
  • Interventional cardiac catheterization. 
  • Intra-aortic balloon counterpulsation in US and non-US centres: results of the Benchmark Registry. 
  • Intracoronary thrombus and complex morphology in unstable angina. Relation to timing of angiography and in-hospital cardiac events. 
  • Intracoronary ultrasound predictors of adverse outcomes after coronary artery interventions. 
  • Intraoperative contrast echocardiography. 
  • Intraoperative echocardiography is indicated in high-risk coronary artery bypass grafting. 
  • Intraoperative transesophageal Doppler color flow imaging used to guide patient selection and operative treatment of ischemic mitral regurgitation. 
  • Intrinsic myocyte dysfunction and tyrosine kinase pathway activation underlie the impaired wall thickening of adjacent regions during postinfarct left ventricular remodeling. 
  • Is noninvasive testing for coronary artery disease accurate? 
  • Is there a bias against performing coronary revascularization in women? 
  • Is there sex bias in the management of coronary artery disease? 
  • Ischemic burden, treatment allocation, and outcomes in stable coronary artery disease. 
  • Ischemic cardiomyopathy: the myopathy of coronary artery disease. Natural history and results of medical versus surgical treatment. 
  • Job strain and the prevalence and outcome of coronary artery disease. 
  • John Henryism and the health of African-Americans. 
  • LDH isoenzymes and myocardial infarction in patients undergoing coronary bypass surgery: an excellent correlation. 
  • Lack of effect of lovastatin on restenosis after coronary angioplasty. Lovastatin Restenosis Trial Study Group. 
  • Laparoscopic nephron-sparing surgery in a Jehovah's Witness patient. 
  • Large scale association analysis for identification of genes underlying premature coronary heart disease: cumulative perspective from analysis of 111 candidate genes. 
  • Laser wire for crossing chronic total occlusions: "learning phase" results from the U.S. TOTAL trial. Total Occlusion Trial With Angioplasty by Using a Laser Wire. 
  • Late outcomes after intervention of vein grafts in diabetics with abciximab use. 
  • Left main stenosis. 
  • Left ventricular dysfunction: causes, natural history, and hopes for reversal. 
  • Left ventricular ejection fraction after acute coronary occlusion in conscious dogs: relation to the extent and site of myocardial infarction. 
  • Left ventricular function under stress before and after myocardial revascularization. 
  • Left ventricular intracavitary mass--an unusual case. 
  • Length of Stay, Mortality, Cost, and Perceptions of Care Associated With Transition From an Open to Closed Staffing Model in the Cardiac Intensive Care Unit. 
  • Lessons learned from a clinical trial. 
  • Life adaptation after percutaneous transluminal coronary angioplasty and coronary artery bypass grafting. 
  • Limited value of interlaced ECG-gated radiography in the presence of a normal chest radiograph. 
  • Linear relationship between the distribution of thallium-201 and blood flow in ischemic and nonischemic myocardium during exercise. 
  • Lipid levels are associated with a regulatory polymorphism of the monoamine oxidase-A gene promoter (MAOA-uVNTR). 
  • Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. 
  • Lipoprotein-Associated Phospholipase A2 Activity Is a Marker of Risk But Not a Useful Target for Treatment in Patients With Stable Coronary Heart Disease. 
  • Living arrangement and coronary heart disease: the JPHC study. 
  • Localization of technetium-99m-sestamibi in diffuse myelodysplastic processes. 
  • Localizing coronary artery obstructions with the exercise treadmill test. 
  • Loneliness and social isolation and increased risk of coronary heart disease and stroke: clinical implications. 
  • Long-term clinical and angiographic outcomes in patients with diabetes undergoing coronary artery bypass graft surgery: results from the Project of Ex-vivo Vein Graft Engineering via Transfection IV trial. 
  • Long-term follow-up of lung volume measurements in initially healthy young aviators. 
  • Long-term mortality of patients undergoing cardiac catheterization for ST-elevation and non-ST-elevation myocardial infarction. 
  • Long-term outcome following successful reopening of abrupt closure after coronary angioplasty. 
  • Long-term predictors of sudden and low output death in chronic congestive heart failure secondary to coronary artery disease. 
  • Long-term protection from myocardial ischemic events in a randomized trial of brief integrin beta3 blockade with percutaneous coronary intervention. EPIC Investigator Group. Evaluation of Platelet IIb/IIIa Inhibition for Prevention of Ischemic Complication. 
  • Long-term results after the glycoprotein IIb/IIIa inhibitor abciximab in unstable angina: one-year survival in the GUSTO IV-ACS (Global Use of Strategies To Open Occluded Coronary Arteries IV--Acute Coronary Syndrome) Trial. 
  • Long-term survival benefits of coronary artery bypass grafting and percutaneous transluminal angioplasty in patients with coronary artery disease. 
  • Longer term benefits of exercise and escitalopram in the treatment of anxiety in patients with coronary heart disease: Six month follow-up of the UNWIND randomized clinical trial. 
  • Longitudinal analysis of the dynamics and risk of coronary heart disease in the Framingham Study. 
  • Loss of Cardioprotective Effects at the ADAMTS7 Locus as a Result of Gene-Smoking Interactions. 
  • Low-molecular-weight heparins and glycoprotein IIb/IIIa inhibitors with percutaneous coronary intervention in acute coronary syndromes. 
  • Magnesium therapy for refractory ventricular fibrillation. 
  • Magnetic resonance assessment of cerebral perfusion in depressed cardiac patients: preliminary findings. 
  • Major lipids, apolipoproteins, and risk of vascular disease. 
  • Management of depression in patients with coronary heart disease: association, mechanisms, and treatment implications for depressed cardiac patients. 
  • Management of patients with acute coronary syndromes in the United States by platelet glycoprotein IIb/IIIa inhibition. Insights from the platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trial. 
  • Managing depression in geriatric populations. 
  • Measures of neuroticism and disease status in coronary angiography patients. 
  • Mechanism of defective oxygen extraction following global ischemia. 
  • Mechanism of protective effects of ACE inhibition on coronary artery disease. 
  • Mechanisms of membrane-receptor regulation. Biochemical, physiological, and clinical insights derived from studies of the adrenergic receptors. 
  • Mechanotransduction Mechanisms for Intraventricular Diastolic Vortex Forces and Myocardial Deformations: Part 2. 
  • Mediation of the APOE associations with Alzheimer's and coronary heart diseases through body mass index and lipids. 
  • Medical appropriateness of coronary angiograms. 
  • Medical care costs and quality of life after randomization to coronary angioplasty or coronary bypass surgery. Bypass Angioplasty Revascularization Investigation (BARI) Investigators. 
  • Medical costs and quality of life 10 to 12 years after randomization to angioplasty or bypass surgery for multivessel coronary artery disease. 
  • Medical, psychological and social correlates of work disability among men with coronary artery disease. 
  • Mental stress--induced myocardial ischemia and cardiac events. 
  • Mental stress-induced ischemia in the laboratory and ambulatory ischemia during daily life. Association and hemodynamic features. 
  • Meta-analysis: retinal vessel caliber and risk for coronary heart disease. 
  • Metabolic deterioration during global ischemia as a function of time in the intact normal dog heart. 
  • Metabolic efficiency with ranolazine for less ischemia in non-ST elevation acute coronary syndromes (MERLIN TIMI-36) study. 
  • Metabolic syndrome, C-reactive protein, and prognosis in patients with established coronary artery disease. 
  • Metabolomic profiling for the identification of novel biomarkers and mechanisms related to common cardiovascular diseases: form and function. 
  • Microparticles in cardiovascular disease pathophysiology and outcomes. 
  • Milrinone use is associated with postoperative atrial fibrillation after cardiac surgery. 
  • Missed opportunities: despite improvement in use of cardioprotective medications among patients with lower-extremity peripheral artery disease, underuse remains. 
  • Misuse of DeLong test to compare AUCs for nested models. 
  • Mode of induction of ventricular tachycardia and prognosis in patients with coronary disease: the Multicenter UnSustained Tachycardia Trial (MUSTT). 
  • Moderate hyperhomocyst(e)inemia is associated with the presence of coronary artery disease and the severity of coronary atherosclerosis in Koreans. 
  • Moderators of the effect of social support on depressive symptoms in cardiac patients. 
  • Modifiable risk factors for vascular access site complications in the IMPACT II Trial of angioplasty with versus without eptifibatide. Integrilin to Minimize Platelet Aggregation and Coronary Thrombosis. 
  • More on the GUSTO trial. 
  • Mortality and need for reoperation in patients with mild-to-moderate asymptomatic aortic valve disease undergoing coronary artery bypass graft alone. 
  • Mortality benefit of beta blockade in patients with acute coronary syndromes undergoing coronary intervention: pooled results from the Epic, Epilog, Epistent, Capture and Rapport Trials. 
  • Mortality model based on delays in progression of chronic diseases: alternative to cause elimination model. 
  • Mortality of the chronically impaired. 
  • Multicenter experience in revascularization of very elderly patients. 
  • Multicenter, randomized, double-blind, placebo-controlled trial of the platelet integrin glycoprotein IIb/IIIa blocker Integrelin in elective coronary intervention. IMPACT Investigators. 
  • Multilead ST-segment monitoring in patients with acute coronary syndromes: a consensus statement for healthcare professionals. ST- Segment Monitoring Practice Guideline International Working Group. 
  • Multiple population models for multivariate random length data--with applications in clinical trials. 
  • Multivessel coronary artery disease: a key predictor of short-term prognosis after reperfusion therapy for acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group. 
  • Music, imagery, touch, and prayer as adjuncts to interventional cardiac care: the Monitoring and Actualisation of Noetic Trainings (MANTRA) II randomised study. 
  • Musical murmurs: clinical implications, long-term prognosis, and echo-phonocardiographic features. 
  • Myocardial distribution of cardioplegic solution after retrograde delivery in patients undergoing cardiac surgical procedures. 
  • Myocardial hypertrophy in the ischemic zone induced by exercise in rats after coronary reperfusion. 
  • Myocardial infarction and stroke. 
  • Myocardial ischemia and adverse cardiac outcomes in cardiac patients undergoing noncardiac surgery with sevoflurane and isoflurane. Sevoflurane Ischemia Study Group. 
  • Myocardial ischemia caused by exercise versus total coronary occlusion. 
  • Myocardial oxygenation in dogs during partial and complete coronary artery occlusion. 
  • Myocardial perfusion and ventricular function measurements during total coronary artery occlusion in humans. A comparison with rest and exercise radionuclide studies. 
  • Myocardial perfusion changes in patients irradiated for left-sided breast cancer and correlation with coronary artery distribution. 
  • Myocardial protection during coronary angioplasty with an autoperfusion balloon catheter in humans. 
  • Myocardial salvage after failed coronary angioplasty. 
  • N-terminal pro-brain natriuretic peptide and outcomes in patients undergoing surgical ventricular restoration. 
  • National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes. 
  • National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: analytical issues for biochemical markers of acute coronary syndromes. 
  • Neighborhood socioeconomic status and the prevalence of stroke and coronary heart disease in rural China: a population-based study. 
  • Neointimal inflammation and adventitial angiogenesis correlate with severity of cardiac allograft vasculopathy in pediatric recipients. 
  • Neurobiology, cellular and molecular biology, and psychosomatic medicine. 
  • New advances in the management of acute coronary syndromes. 
  • New concept in coronary angioplasty: dilatation with a helical balloon that allows simultaneous autoperfusion. 
  • New interventional technology for the management of multivessel coronary artery disease. 
  • New loci and coding variants confer risk for age-related macular degeneration in East Asians. 
  • New paradigms in cardiovascular medicine: emerging technologies and practices: perioperative genomics. 
  • New strategies in the management of acute coronary syndromes. 
  • Nifedipine in the treatment of hypertensive episodes in the coronary care unit. 
  • No jacket required. 
  • No laughing matter. 
  • Non-invasive characterization of complex coronary lesions. 
  • Nonfatal myocardial infarction in medically treated patients with coronary artery disease. 
  • Noninvasive assessment of patients following coronary artery angioplasty. 
  • Noninvasive detection of periinduction ischemic ventricular dysfunction by cardiokymography in humans: preliminary experience. 
  • Noninvasive, medical management for non-ST-elevation acute coronary syndromes. 
  • Nonpharmacologic and pharmacologic treatment of patients with low levels of high-density lipoprotein cholesterol. 
  • Nonpharmacologic treatments for depression in patients with coronary heart disease. 
  • Nonsustained ventricular tachycardia in coronary artery disease: relation to inducible sustained ventricular tachycardia. MUSTT Investigators. 
  • Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): a randomised, placebo-controlled trial. 
  • Obesity and long-term clinical and economic outcomes in coronary artery disease patients. 
  • Observational comparison of event-free survival with medical and surgical therapy in patients with coronary artery disease. 20 years of follow-up. 
  • Obstructive coronary atherosclerosis and ischemic heart disease: an elusive link! 
  • Off-pump coronary artery bypass grafting. Excellent results in a group of selected high-risk patients. 
  • Off-pump coronary bypass provides reduced mortality and morbidity and equivalent 10-year survival. 
  • On mechanisms of improved ejection fraction by early reperfusion in acute myocardial infarction: myocardial salvage or infarct stiffening? 
  • On-pump versus off-pump coronary-artery bypass surgery. 
  • Onset and extent of platelet inhibition by clopidogrel loading in patients undergoing elective coronary stenting: the Plavix Reduction Of New Thrombus Occurrence (PRONTO) trial. 
  • Operator-specific outcomes. A call to professional responsibility. 
  • Optimal duration of eptifibatide infusion in percutaneous coronary intervention (an ESPRIT substudy). 
  • Optimal timing of intervention in non-ST-segment elevation acute coronary syndromes: insights from the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines) Registry. 
  • Optimization of tube current in coronary multidetector computed tomography angiography: assessment of a standardized method to individualize current selection based on body habitus. 
  • Optimizing platelet P2Y12 inhibition for patients undergoing PCI. 
  • Oral glycoprotein IIb/IIIa antagonists: new insights from the SYMPHONY trial. 
  • Oral platelet IIb/IIIa inhibitors: from attractive theory to clinical failures. 
  • Origins and consequences of vascular calcification. 
  • Outcome after prolonged balloon inflations of greater than 20 minutes for initially unsuccessful percutaneous transluminal coronary angioplasty. 
  • Outcome in medically treated coronary artery disease. Ischemic events: nonfatal infarction and death. 
  • Outcome in one-vessel coronary artery disease. 
  • Outcome of coronary bypass surgery versus coronary angioplasty in diabetic patients with multivessel coronary artery disease. 
  • Outcome of patients with diabetes mellitus and acute myocardial infarction treated with thrombolytic agents. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group. 
  • Outcome prediction in patients at high risk for coronary artery disease: comparison between 99mTc tetrofosmin and 99mTc sestamibi. 
  • Outcomes after percutaneous coronary artery revascularization procedures for cardiac allograft vasculopathy in pediatric heart transplant recipients: A multi-institutional study. 
  • Outcomes at 1 year and economic implications of platelet glycoprotein IIb/IIIa blockade in patients undergoing coronary stenting: results from a multicentre randomised trial. EPISTENT Investigators. Evaluation of Platelet IIb/IIIa Inhibitor for Stenting. 
  • Outcomes following interventions in small coronary arteries with the use of hand-crimped Palmaz-Schatz stents. 
  • Outcomes of cardiac surgery in patients > or = 80 years: results from the National Cardiovascular Network. 
  • Outcomes of patients with acute coronary syndromes and prior coronary artery bypass grafting: results from the platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trial. 
  • PCSK9 Loss-of-Function Variants, Low-Density Lipoprotein Cholesterol, and Risk of Coronary Heart Disease and Stroke: Data From 9 Studies of Blacks and Whites. 
  • Painless exercise ST deviation on the treadmill: long-term prognosis. 
  • Pancreatic beta-cell function as a predictor of cardiovascular outcomes and costs: findings from the Cardiovascular Health Study. 
  • Para-[18F]fluorobenzylguanidine kinetics in a canine coronary artery occlusion model. 
  • Paracrine mechanisms in adult stem cell signaling and therapy. 
  • Parenthood and the risk of cardiovascular diseases among 0.5 million men and women: findings from the China Kadoorie Biobank. 
  • Pathophysiology and therapeutic modification of thrombin generation in patients with coronary artery disease. 
  • Pathophysiology and time course of silent myocardial ischaemia during mental stress: clinical, anatomical, and physiological correlates. 
  • Patient survival characteristics after routine mitral valve repair for ischemic mitral regurgitation. 
  • Perceived Discrimination and Cardiovascular Outcomes in Older African Americans: Insights From the Jackson Heart Study. 
  • Perceived social support as a predictor of mortality in coronary patients: effects of smoking, sedentary behavior, and depressive symptoms. 
  • Percutaneous coronary intervention versus coronary artery bypass grafting for diabetics with multivessel coronary artery disease: the Korean Multicenter Revascularization Registry (KORR). 
  • Percutaneous revascularization of chronic coronary occlusions: an overview. 
  • Percutaneous transluminal coronary angioplasty as a first revascularization procedure in single-, double- and triple-vessel coronary artery disease. 
  • Performance of a population-based cardiac risk stratification tool in Asian patients with chest pain. 
  • Performance of an automated real-time ST-segment analysis program to detect coronary occlusion and reperfusion. 
  • Performance of current guidelines for coronary heart disease prevention: optimal use of the Framingham-based risk assessment. 
  • Performance status and outcome after coronary artery bypass grafting in persons aged 80 to 93 years. 
  • Perfusion and function assessment by nuclear cardiology techniques. 
  • Perfusion balloon angioplasty in patients with complex coronary lesion morphology. 
  • Perfusion balloon catheter. 
  • Periodontal disease in patients with chronic coronary heart disease: Prevalence and association with cardiovascular risk factors. 
  • Periodontal health improves systemic inflammatory and haemostatic status in subjects with coronary heart disease. 
  • Perioperative morbidity and mortality after transmyocardial laser revascularization: incidence and risk factors for adverse events. 
  • Perioperative morbidity and mortality in combined vs. staged approaches to carotid and coronary revascularization. 
  • Peripheral vascular complications in the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT-I). 
  • Periprocedural myocardial ischemia in patients with severe symptomatic coronary artery disease undergoing endoscopy: prevalence and risk factors. 
  • Personality, type A behavior, and coronary heart disease: the role of emotional expression. 
  • Pharmacokinetic studies: their role in determining therapeutic efficacy of agents designed to prevent sudden death. 
  • Pharmacokinetics of antisense oligodeoxyribonucleotides (cyclin B1 and CDC 2 kinase) in the vessel wall in vivo: enhanced therapeutic utility for restenosis by HVJ-liposome delivery. 
  • Pharmacological strategies to prevent restenosis: lessons learned from blockade of the renin-angiotensin system. 
  • Pharmacological treatment of elderly patients with acute coronary syndromes without persistent ST segment elevation. 
  • Phobic anxiety and increased risk of mortality in coronary heart disease. 
  • Phobic anxiety, depression, and risk of ventricular arrhythmias in patients with coronary heart disease. 
  • Physical Activity and Mortality in Patients With Stable Coronary Heart Disease. 
  • Physical Activity, All-Cause and Cardiovascular Mortality, and Cardiovascular Disease. 
  • Physical activity in patients with stable coronary heart disease: an international perspective. 
  • Physician decision making and trends in the use of cardiac stress testing in the United States: an analysis of repeated cross-sectional data. 
  • Physiological basis for potassium (39K) magnetic resonance imaging of the heart. 
  • Pitfalls of chest pain. Pseudoxanthoma elasticum. 
  • Plasma fibrinogen levels and their correlates in 6457 coronary heart disease patients. The Bezafibrate Infarction Prevention (BIP) Study. 
  • Platelet function analyzer (PFA)-100 closure time in the evaluation of platelet disorders and platelet function. 
  • Platelet function and total length of intracoronary stents: is there a correlation? 
  • Platelet function monitoring in patients with coronary artery disease. 
  • Platelet glycoprotein IIb/IIIa integrin blockade: recent clinical trials in interventional cardiology. 
  • Platelet glycoprotein IIb/IIIa receptor antagonists in non-ST segment elevation acute coronary syndromes: a review and guide to patient selection. 
  • Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. 
  • Platelet inhibition by sertraline and N-desmethylsertraline: a possible missing link between depression, coronary events, and mortality benefits of selective serotonin reuptake inhibitors. 
  • Platelet monitoring for PCI: is it really necessary? 
  • Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study. 
  • Platelet/endothelial biomarkers in depressed patients treated with the selective serotonin reuptake inhibitor sertraline after acute coronary events: the Sertraline AntiDepressant Heart Attack Randomized Trial (SADHART) Platelet Substudy. 
  • Playing the odds. 
  • Pleiotropic Associations of Allelic Variants in a 2q22 Region with Risks of Major Human Diseases and Mortality. 
  • Polymorphism of angiotensin converting enzyme gene is associated with circulating levels of plasminogen activator inhibitor-1. 
  • Poor oral health is associated with coronary heart disease and elevated systemic inflammatory and haemostatic factors. 
  • Poor performance of lead V5 in single- and dual-channel ST-segment monitoring during coronary occlusion. 
  • Population impact of mortality reduction: the effects of elimination of major causes of death on the 'saved' population. 
  • Population-level incidence and outcomes of myocardial infarction with non-obstructive coronary arteries (MINOCA): Insights from the Alberta contemporary acute coronary syndrome patients invasive treatment strategies (COAPT) study. 
  • Post-procedure heparin: boon or burden? 
  • Postmenopausal hormone use in women with acute coronary syndromes. 
  • Postmortem validation of the automated coronary analysis (ACA) software package. 
  • Poststress measurements of left ventricular function with gated perfusion SPECT: comparison with resting measurements by using a same-day perfusion-function protocol. 
  • Potential impact of evidence-based medicine in acute coronary syndromes: insights from GUSTO-IIb. Global Use of Strategies to Open Occluded Arteries in Acute Coronary Syndromes trial. 
  • Potential of an intracardiac electrogram for the rapid detection of coronary artery occlusion. 
  • Poverty, process of care, and outcome in acute coronary syndromes. 
  • Practice still makes perfect. 
  • Prasugrel. 
  • Pre-hospital synthesized 12-lead ECG ischemia monitoring with trans-telephonic transmission in acute coronary syndromes: pilot study results of the ST SMART trial. 
  • Predicting adverse outcome with exercise SPECT technetium-99m sestamibi imaging in patients with suspected or known coronary artery disease. 
  • Predicting outcome in coronary disease. Statistical models versus expert clinicians. 
  • Predicting personality in adulthood from college MMPI scores: implications for follow-up studies in psychosomatic medicine. 
  • Predicting significant coronary artery disease in patients with left ventricular dysfunction. 
  • Predicting the future of human gene therapy for cardiovascular diseases: what will the management of coronary artery disease be like in 2005 and 2010? 
  • Predicting the risk of abrupt vessel closure after angioplasty in an individual patient. 
  • Prediction of 1-year survival after thrombolysis for acute myocardial infarction in the global utilization of streptokinase and TPA for occluded coronary arteries trial. 
  • Prediction of Residual Risk by Ceramide-Phospholipid Score in Patients With Stable Coronary Heart Disease on Optimal Medical Therapy. 
  • Prediction of death and myocardial infarction by radionuclide angiocardiography in patients with suspected coronary artery disease. 
  • Prediction of early recurrent myocardial ischemia and coronary reocclusion after successful thrombolysis: a qualitative and quantitative angiographic study. 
  • Prediction of long-term outcomes by signal-averaged electrocardiography in patients with unsustained ventricular tachycardia, coronary artery disease, and left ventricular dysfunction. 
  • Prediction of major vascular events after stroke: the stroke prevention by aggressive reduction in cholesterol levels trial. 
  • Prediction of myocardial perfusion abnormalities by quantitative regional function using a radionuclide angiography database: a comparison with wall motion analysis. 
  • Prediction of severe coronary artery disease by combined rest and exercise radionuclide angiocardiography and tomographic perfusion imaging with technetium 99m-labeled sestamibi: a comparison with clinical and electrocardiographic data. 
  • Prediction of subsequent ischemic heart disease using serial resting electrocardiograms. 
  • Prediction of sustained ventricular tachycardia inducible by programmed stimulation in patients with coronary artery disease. Utility of clinical variables. 
  • Predictive Utility of a Validated Polygenic Risk Score for Long-Term Risk of Coronary Heart Disease in Young and Middle-Aged Adults. 
  • Predictors of acute and long-term outcome with transluminal extraction atherectomy: the New Approaches to Coronary Intervention (NACI) registry. 
  • Predictors of outcome of percutaneous excimer laser coronary angioplasty of saphenous vein bypass graft lesions. The Percutaneous Excimer Laser Coronary Angioplasty Registry. 
  • Predictors of smoking cessation in patients with a diagnosis of coronary artery disease. 
  • Pregnancy, pregnancy loss, and the risk of cardiovascular disease in Chinese women: findings from the China Kadoorie Biobank. 
  • Preliminary report on the interaction of apolipoprotein E polymorphism with aortic atherosclerosis and acute nephropathy after CABG. 
  • Preoperative assessment of left ventricular function in patients selected for direct myocardial revascularization. 
  • Preoperative determinants of postoperative costs associated with coronary artery bypass graft surgery. 
  • Preoteomics, metabolomics and progenitor cells in acute coronary syndromes. 
  • Pretreatment with an inhibitor of mac-1 alters regional and systemic platelet function during ischemia-reperfusion in swine. 
  • Prevalence and clinical characteristics of mental stress-induced myocardial ischemia in patients with coronary heart disease. 
  • Prevalence and management of hypertension in acute coronary syndrome patients varies by sex: observations from the Sibrafiban versus aspirin to Yield Maximum Protection from ischemic Heart events postacute cOroNary sYndromes (SYMPHONY) randomized clinical trials. 
  • Prevalence and significance of atrial fibrillation in coronary artery disease (CASS Registry). 
  • Prevalence of anxiety disorders in men and women with established coronary heart disease. 
  • Prevalence of conventional risk factors in patients with coronary heart disease. 
  • Prevalence, predisposing factors, and prognosis of clinically unrecognized myocardial infarction in the elderly. 
  • Prevalences of type 2 diabetes, the insulin resistance syndrome, and coronary heart disease in an elderly, biethnic population. 
  • Prevention of ischemically induced neointimal hyperplasia using ex vivo antisense oligodeoxynucleotides. 
  • Prevention of sudden death in patients with coronary artery disease. 
  • Prevention of sudden death in patients with coronary artery disease: the Multicenter Unsustained Tachycardia Trial (MUSTT). 
  • Primary prevention and statins: is it just about going to class? 
  • Problems and advantages of an observational data base approach to evaluating the effect of therapy on outcome. 
  • Problems in data management when studying chronic illness. 
  • Probucol prevents early coronary heart disease and death in the high-density lipoprotein receptor SR-BI/apolipoprotein E double knockout mouse. 
  • Procainamide delivery to ischemic canine myocardium following rapid intravenous administration. 
  • Prognosis and management of anterolateral myocardial infarction in patients with severe left main disease and cardiogenic shock. The left main shock syndrome. 
  • Prognosis by measurements of left ventricular function during exercise. Duke Noninvasive Research Working Group. 
  • Prognostic biomarkers in individuals with prevalent coronary heart disease. 
  • Prognostic implications of angiographically normal and insignificantly narrowed coronary arteries. 
  • Prognostic implications of ventricular arrhythmias during 24 hour ambulatory monitoring in patients undergoing cardiac catheterization for coronary artery disease. 
  • Prognostic importance of concomitant heparin with eptifibatide in acute coronary syndromes. PURSUIT Investigators. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy. 
  • Prognostic importance of new small Q waves following non-ST-elevation acute coronary syndromes. 
  • Prognostic importance of social and economic resources among medically treated patients with angiographically documented coronary artery disease. 
  • Prognostic indicators from radionuclide angiography in medically treated patients with coronary artery disease. 
  • Prognostic significance of exercise-induced complex ventricular arrhythmias in coronary artery disease with normal and abnormal left ventricular ejection fraction. 
  • Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. 
  • Prognostic value of a coronary artery jeopardy score. 
  • Prognostic value of a treadmill exercise score in outpatients with suspected coronary artery disease. 
  • Prognostic value of congestive heart failure history in patients undergoing percutaneous coronary interventions. 
  • Prognostic value of growth-differentiation factor-15 in patients with non-ST-elevation acute coronary syndrome. 
  • Prognostic value of normal exercise and adenosine (99m)Tc-tetrofosmin SPECT imaging: results from the multicenter registry of 4,728 patients. 
  • Prognostic value of radionuclide angiography in medically treated patients with coronary artery disease. A comparison with clinical and catheterization variables. 
  • Prognostic value of serial B-type natriuretic peptide testing during follow-up of patients with unstable coronary artery disease. 
  • Prognostic value of thallium-201 single-photon emission computed tomography for patients with multivessel coronary artery disease after revascularization (the Emory Angioplasty versus Surgery Trial [EAST]). 
  • Prognostic value of the simplified Selvester QRS score in patients with coronary artery disease. 
  • Prognostic value of ventricular arrhythmias associated with treadmill exercise testing in patients studied with cardiac catheterization for suspected ischemic heart disease. 
  • Progress in the treatment of acute coronary syndromes: a 50-year perspective (1950-2000). 
  • Promise of combined low-molecular-weight heparin and platelet glycoprotein IIb/IIIa inhibition: results from Platelet IIb/IIIa Antagonist for the Reduction of Acute coronary syndrome events in a Global Organization Network B (PARAGON B). 
  • Prospective Association of Daily Steps With Cardiovascular Disease: A Harmonized Meta-Analysis. 
  • Prospective associations of coronary heart disease loci in African Americans using the MetaboChip: the PAGE study. 
  • Prospective study of perceived stress in cardiac patients. 
  • Protection of mitochondrial function during ischemia by potassium cardioplegia: correlation with ischemic contracture. 
  • Provisional stenting strategies: systematic overview and implications for clinical decision-making. 
  • Psychobehavioral treatment in cardiac rehabilitation. 
  • Psychological correlates of hostility among patients undergoing coronary angiography. 
  • Psychological factors in coronary artery disease: epidemiologic evidence. 
  • Psychological predictors of heart disease: a quantitative review. 
  • Psychological risk factors in coronary artery disease. 
  • Psychosocial and biobehavioral factors and their interplay in coronary heart disease. 
  • Psychosocial and physical predictors of anginal pain relief with medical management. 
  • Psychosocial factors and coronary disease. A national multicenter clinical trial (ENRICHD) with a North Carolina focus. 
  • Psychosocial factors and prognosis in established coronary artery disease. The need for research on interventions. 
  • Psychosocial factors: role in cardiac risk and treatment strategies. 
  • Psychosocial stress and major cardiovascular events in patients with stable coronary heart disease. 
  • Psychosocial training and cardiac rehabilitation. 
  • Pulmonary artery catheterization in acute coronary syndromes: insights from the GUSTO IIb and GUSTO III trials. 
  • Pulmonary thromboendarterectomy combined with other cardiac operations: indications, surgical approach, and outcome. 
  • Pulse pressure and long-term survival after coronary artery bypass graft surgery. 
  • Pursuing progress in acute coronary syndromes. 
  • QRS changes during acute ischemia induced by balloon occlusion of the LAD artery. 
  • Quality of care and in-hospital outcomes in patients with coronary heart disease in rural and urban hospitals (from Get With the Guidelines-Coronary Artery Disease Program). 
  • Quality of life after coronary angioplasty or continued medical treatment for angina: three-year follow-up in the RITA-2 trial. Randomized Intervention Treatment of Angina. 
  • Quality of life and recovery after cardiac surgery. 
  • Quantification of ST-segment changes during coronary angioplasty in patients with left bundle branch block. 
  • Quantification of myocardial hypoperfusion with 99m Tc-sestamibi in patients undergoing prolonged coronary artery balloon occlusion. 
  • Quantification of myocardial infarction during coronary occlusion and myocardial salvage after reperfusion using cardiac imaging with technetium-99m hexakis 2-methoxyisobutyl isonitrile. 
  • Quantification of regional myocardial dysfunction after acute ischemic injury. 
  • Quantifying Importance of Major Risk Factors for Coronary Heart Disease. 
  • Quantifying the contributions of behavioral and biological risk factors to socioeconomic disparities in coronary heart disease incidence: the MORGEN study. 
  • Quantitation of ischemia during total coronary occlusion with computer-assisted high resolution ST-segment monitoring: effect of collateral flow. 
  • Quantitative ST-segment recovery following angiographically successful angioplasty: a useful warning of early complications. 
  • Quantitative and qualitative ST segment monitoring during and after percutaneous transluminal coronary angioplasty. 
  • Quantitative and qualitative coronary angiographic analysis: review of methods, utility, and limitations. 
  • Quantitative thallium-201 single photon emission computed tomography after oral dipyridamole for assessing the presence, anatomic location and severity of coronary artery disease. 
  • Racial differences among high-risk patients presenting with non-ST-segment elevation acute coronary syndromes (results from the SYNERGY trial). 
  • Racial differences in outcome in the Multicenter UnSustained Tachycardia Trial (MUSTT): a comparison of whites versus blacks. 
  • Racial differences in the relationship between alcohol consumption in early adulthood and occupational attainment at midlife. 
  • Racial differences of lipoprotein subclass distributions in postmenopausal women. 
  • Racial variation in the use of coronary-revascularization procedures. Are the differences real? Do they matter? 
  • Radionuclide viability testing: should it affect treatment strategy in patients with cardiomyopathy and significant coronary artery disease? 
  • Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade. 
  • Randomised placebo-controlled trial of effect of eptifibatide on complications of percutaneous coronary intervention: IMPACT-II. Integrilin to Minimise Platelet Aggregation and Coronary Thrombosis-II. 
  • Randomised trials of secondary prevention programmes in coronary heart disease: systematic review. 
  • Randomized COMparison of platelet inhibition with abciximab, tiRofiban and eptifibatide during percutaneous coronary intervention in acute coronary syndromes: the COMPARE trial. Comparison Of Measurements of Platelet aggregation with Aggrastat, Reopro, and Eptifibatide. 
  • Randomized Evaluation of the Effects of Anacetrapib through Lipid-modification (REVEAL)-A large-scale, randomized, placebo-controlled trial of the clinical effects of anacetrapib among people with established vascular disease: Trial design, recruitment, and baseline characteristics. 
  • Randomized evaluation of the safety and efficacy of enoxaparin versus unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes receiving the glycoprotein IIb/IIIa inhibitor eptifibatide. 
  • Randomized trial of aspirin, sibrafiban, or both for secondary prevention after acute coronary syndromes. 
  • Randomized trial of contrast media utilization in high-risk PTCA: the COURT trial. 
  • Randomized trials of coronary artery bypass surgery: impact on clinical practice at Duke University Medical Center. 
  • Randomized, double-blind, dose-ranging study of otamixaban, a novel, parenteral, short-acting direct factor Xa inhibitor, in percutaneous coronary intervention: the SEPIA-PCI trial. 
  • Randomized, double-blind, placebo-controlled, international trial of the oral IIb/IIIa antagonist lotrafiban in coronary and cerebrovascular disease. 
  • Rapid assessment of glycoprotein IIb/IIIa blockade with the platelet function analyzer (PFA-100) during percutaneous coronary intervention. 
  • Rapidly progressing mycotic aortic aneurysm masquerading as acute coronary syndrome. 
  • Ratings of positive and depressive emotion as predictors of mortality in coronary patients. 
  • Rationale and clinical evidence for the use of GP IIb/IIIa inhibitors in acute coronary syndromes. 
  • Rationale and clinical evidence for the use of GP IIb/IIIa inhibitors in acute coronary syndromes. 
  • Rationale and design of the CONFIRM (COronary CT Angiography EvaluatioN For Clinical Outcomes: An InteRnational Multicenter) Registry. 
  • Rationale and design of the GRACE (Global Registry of Acute Coronary Events) Project: a multinational registry of patients hospitalized with acute coronary syndromes. 
  • Readministration of abciximab: interim report of the ReoPro readministration registry. 
  • Real-time detection and alerting for acute ST-segment elevation myocardial ischemia using an implantable, high-fidelity, intracardiac electrogram monitoring system with long-range telemetry in an ambulatory porcine model. 
  • Real-time, volumetric echocardiography: usefulness of volumetric scanning for the assessment of cardiac volume and function. 
  • Recent antiplatelet drug trials in the acute coronary syndromes. Clinical interpretation of PRISM, PRISM-PLUS, PARAGON A and PURSUIT. 
  • Recommendations for the assessment and maintenance of proficiency in coronary interventional procedures: Statement of the American College of Cardiology. 
  • Recommendations of the Adult Treatment Panel of the National Cholesterol Education Program. Implications for the management of hypertension. 
  • Recovery and survival from aging-associated diseases. 
  • Recovery expectations and long-term prognosis of patients with coronary heart disease. 
  • Red cell distribution width, C-reactive protein, the complete blood count, and mortality in patients with coronary disease and a normal comparison population. 
  • Reduced kidney function as a risk factor for incident heart failure: the atherosclerosis risk in communities (ARIC) study. 
  • Reduced oxygen extraction during reperfusion: a consequence of global ischemic arrest. 
  • Reduction in the need for unplanned stenting with the use of platelet glycoprotein IIb/IIIa blockade in percutaneous coronary intervention. 
  • Reduction of myocardial ischemia during percutaneous transluminal coronary angioplasty with oxygenated Fluosol. 
  • Reduction of myocardial ischemic injury following coronary intervention (the MC-1 to Eliminate Necrosis and Damage trial). 
  • Referral patterns for coronary artery disease treatment: gender bias or good clinical judgment? 
  • Refining the type A hypothesis: emergence of the hostility complex. 
  • Regional cardiac sympathetic innervation early and late after transmyocardial laser revascularization. 
  • Regression modelling strategies for improved prognostic prediction. 
  • Relation between aspirin dose, all-cause mortality, and bleeding in patients with recent cerebrovascular or coronary ischemic events (from the BRAVO Trial). 
  • Relation between baseline risk and treatment decisions in non-ST elevation acute coronary syndromes: an examination of international practice patterns. 
  • Relation between coronary artery stenosis assessed by visual, caliper, and computer methods and exercise capacity in patients with single-vessel coronary artery disease. The Veterans Affairs ACME Investigators. 
  • Relation between estrogen replacement therapy and restenosis after percutaneous coronary interventions. 
  • Relation between inhibition of platelet aggregation and clinical outcomes. 
  • Relation between myocardial perfusion and left ventricular function following acute coronary occlusion: disproportionate effects of anterior vs. inferior ischemia. 
  • Relation between radionuclide angiographic regional ejection fraction and left ventricular regional ischemia in awake dogs. 
  • Relation between reversal of diastolic creep and recovery of systolic function after ischemic myocardial injury in conscious dogs. 
  • Relation of an elevated white blood cell count after percutaneous coronary intervention to long-term mortality. 
  • Relation of angiographic detected intracoronary thrombus and silent myocardial ischemia in unstable angina pectoris. 
  • Relation of cardiovascular responses to mental stress and cardiac vagal activity in coronary artery disease. 
  • Relation of clinical and angiographic factors to functional capacity as measured by the Duke Activity Status Index. 
  • Relation of lumen size to restenosis after percutaneous transluminal coronary balloon angioplasty. Lovastatin Restenosis Trial Group. 
  • Relation of quantitative coronary lesion measurements to the development of exercise-induced ischemia assessed by exercise echocardiography. 
  • Relations between deletion polymorphism of the angiotensin-converting enzyme gene and insulin resistance, glucose intolerance, hyperinsulinemia, and dyslipidemia. 
  • Relationship between activated clotting time during percutaneous intervention and subsequent bleeding complications. 
  • Relationship between birth size and coronary heart disease in China. 
  • Relationship between diabetes mellitus and long-term survival after coronary bypass and angioplasty. 
  • Relationship between regional myocardial procainamide concentration and regional myocardial blood flow during ischemia in the dog. 
  • Relationship between release of platelet/endothelial biomarkers and plasma levels of sertraline and N-desmethylsertraline in acute coronary syndrome patients receiving SSRI treatment for depression. 
  • Relationship of extent of revascularization with angina at one year in the Bypass Angioplasty Revascularization Investigation (BARI). 
  • Relationship of preoperative antiendotoxin core antibodies and adverse outcomes following cardiac surgery. 
  • Relationships among age, sex, the type A behavior pattern, and cardiovascular reactivity. 
  • Relationships among ventricular arrhythmias, coronary artery disease, and angiographic and electrocardiographic indicators of myocardial fibrosis. 
  • Release of arachidonate from membrane phospholipids in cultured neonatal rat myocardial cells during adenosine triphosphate depletion. Correlation with the progression of cell injury. 
  • Reliability of single-lead and multiple-lead electrocardiography during and after exercise. 
  • Religion, Spirituality and Risk of Coronary Heart Disease: A Matched Case-Control Study and Meta-Analysis. 
  • Renal artery stenosis is not associated with the development of acute renal failure following coronary artery bypass grafting. 
  • Renal function, concomitant medication use and outcomes following acute coronary syndromes. 
  • Repeat percutaneous transluminal coronary angioplasty and predictors of recurrent restenosis. 
  • Reperfusion and revascularization strategies for coronary artery disease in women. 
  • Reply: To PMID 22954239. 
  • Reply: To PMID 24360877. 
  • Representation of elderly persons and women in published randomized trials of acute coronary syndromes. 
  • Resolved and unresolved issues in the prevention and treatment of coronary artery disease: a workshop consensus statement. 
  • Resolved: psychosocial interventions can improve clinical outcomes in organic disease (pro). 
  • Resolved: psychosocial interventions can improve clinical outcomes in organic disease--rebuttals and closing arguments. 
  • Response to Letter Regarding Article, "Association of Race With Mortality and Cardiovascular Events in a Large Cohort of US Veterans". 
  • Rest and exercise cardiac output and diffusing capacity assessed by a single slow exhalation of methane, acetylene, and carbon monoxide. 
  • Restenosis after coronary angioplasty: an overview. 
  • Restenosis, reocclusion and adverse cardiovascular events after successful balloon angioplasty of occluded versus nonoccluded coronary arteries. Results from the Multicenter American Research Trial With Cilazapril After Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MARCATOR). 
  • Results of Expert Meetings: Obesity and Cardiovascular Disease. Introduction: Cardiologists should target obesity. 
  • Results of Expert Meetings: Obesity and Cardiovascular Disease. Obesity as a risk factor in coronary artery disease. 
  • Results of high dose intravenous urokinase for acute myocardial infarction. 
  • Rethinking sensitivity and specificity. 
  • Rethinking stable ischemic heart disease: is this the beginning of a new era? 
  • Retinal arterial signs and coronary heart disease. 
  • Retinal arteriolar narrowing and risk of coronary heart disease in men and women. The Atherosclerosis Risk in Communities Study. 
  • Retinal vascular calibre and the risk of coronary heart disease-related death. 
  • Retinal vessel diameter and cardiovascular mortality: pooled data analysis from two older populations. 
  • Retinopathy predicts coronary heart disease mortality. 
  • Review of the 2005 American College of Cardiology, American Heart Association, and Society for Cardiovascular Interventions guidelines for adjunctive pharmacologic therapy during percutaneous coronary interventions: practical implications, new clinical data, and recommended guideline revisions. 
  • Right and left ventricular performance during and after abdominal aortic aneurysm repair. 
  • Right ventricular aneurysm due to ischemic disease. Diagnosis by radionuclide angiography with localization of the site of PVC origin by phase analysis. 
  • Right-heart catheterization in coronary artery disease. 
  • Risk factors for conversion to cardiopulmonary bypass during off-pump coronary artery bypass surgery. 
  • Risk markers of incident atrial fibrillation in patients with coronary heart disease. 
  • Risk of distal embolization and infarction with transluminal extraction atherectomy in saphenous vein grafts and native coronary arteries. NACI Investigators. New Approaches to Coronary Interventions. 
  • Risk of ischemic heart disease in patients with TIA. 
  • Risk prediction of coronary heart disease based on retinal vascular caliber (from the Atherosclerosis Risk In Communities [ARIC] Study). 
  • Risk stratification for adverse economic outcomes in cardiac surgery. 
  • Risk stratification in patients with chest pain. 
  • Risk stratification in patients with chest pain. 
  • Role of coronary angiography in acute coronary artery syndromes. 
  • Role of resting thallium201 perfusion in predicting coronary anatomy, left ventricular wall motion, and hospital outcome in unstable angina pectoris. 
  • Role of target vessel size and body surface area on outcomes after percutaneous coronary interventions in women. 
  • Ruminating on OAT: is the case closed? 
  • SYNTAX Score and Long-Term Outcomes: The BARI-2D Trial. 
  • Safe pancreas transplantation in patients with coronary artery disease. 
  • Safety and antiplatelet effect of murine monoclonal antibody 7E3 Fab directed against platelet glycoprotein IIb/IIIa in patients undergoing elective coronary angioplasty. 
  • Safety and efficacy of abciximab combined with dalteparin in treatment of acute coronary syndromes. 
  • Safety and tolerability of SCH 530348 in patients undergoing non-urgent percutaneous coronary intervention: a randomised, double-blind, placebo-controlled phase II study. 
  • Saline infusion in excimer laser coronary angioplasty. 
  • Secular trends in ischemic heart disease mortality: regional variation. 
  • Seeking the optimal aspirin dose in acute coronary syndromes. 
  • Selective cine coronary angiography in the diagnosis of ischemic heart disease. 
  • Self-Reported Health and Outcomes in Patients With Stable Coronary Heart Disease. 
  • Self-ratings of type A (coronary prone) adults: do type A's know they are type A's? 
  • Self-report of chest pain symptoms and coronary artery disease in patients undergoing angiography. 
  • Sensitivity and specificity can change in opposite directions when new predictive markers are added to risk models. 
  • Serial measurements of N-terminal pro-brain natriuretic peptide in patients with coronary heart disease. 
  • Serum cholesterol in patients undergoing cardiac catheterization for suspected coronary artery disease: diagnostic and prognostic implications. 
  • Serum lipids, neuroendocrine and cardiovascular responses to stress in healthy Type A men. 
  • Sex Difference in Patients With Ischemic Heart Failure Undergoing Surgical Revascularization: Results From the STICH Trial (Surgical Treatment for Ischemic Heart Failure). 
  • Sex and race specific mortality differentials in multiple cause of death data. 
  • Sex-Based Differences in Cessation of Dual-Antiplatelet Therapy Following Percutaneous Coronary Intervention With Stents. 
  • Sex-specific differences in coronary artery disease risk factors, evaluation, and treatment: have they been adequately evaluated? 
  • Short- and long-term outcomes of coronary stenting in women versus men: results from the National Cardiovascular Data Registry Centers for Medicare & Medicaid services cohort. 
  • Should stress management be incorporated into cardiac rehabilitation? 
  • Should we measure C-reactive protein levels to ascertain the adequacy of statin therapy in patients who are at very high risk for a coronary heart disease event? 
  • Significance of a coronary artery with thrombolysis in myocardial infarction grade 2 flow "patency" (outcome in the thrombolysis and angioplasty in myocardial infarction trials). Thrombolysis and Angioplasty in Myocardial Infarction Study Group. 
  • Significant sex differences in the correlation of electrocardiographic exercise testing and coronary arteriograms. 
  • Simultaneous comparison of three derived 12-lead ECGs with standard ECG at rest and during percutaneous coronary occlusion. 
  • Simultaneous measurement of myocardial perfusion and ventricular function during exercise from a single injection of technetium-99m sestamibi in coronary artery disease. 
  • Single-photon emission computed tomography myocardial perfusion imaging and the risk of sudden cardiac death in patients with coronary disease and left ventricular ejection fraction>35%. 
  • Situational determinants of cardiovascular and emotional reactivity in high and low hostile men. 
  • Six-month outcomes of percutaneous coronary balloon angioplasty in acute coronary syndromes: Results from the PURSUIT trial. 
  • Sleep-disordered breathing is not associated with the presence of retinal microvascular abnormalities: the Sleep Heart Health Study. 
  • Small-molecule glycoprotein IIb/IIIa inhibitors as adjunctive therapy in percutaneous coronary interventions. 
  • Social dominance and 22-year all-cause mortality in men. 
  • Social support and coronary heart disease: epidemiologic evidence and implications for treatment. 
  • Social support and hostility as predictors of depressive symptoms in cardiac patients one month after hospitalization: a prospective study. 
  • Social support and quality of life in patients with coronary artery disease. 
  • Social support and religiosity as coping strategies for anxiety in hospitalized cardiac patients. 
  • Social support, type A behavior, and coronary artery disease. 
  • Socioeconomic influences on coronary heart disease in black populations. 
  • Soluble VCAM-1 and E-selectin, but not ICAM-1 discriminate endothelial injury in patients with documented coronary artery disease. 
  • Sonomicrometric determination of ischemic contracture of the left ventricle. 
  • Spectrum of coronary artery disease in idiopathic hypertrophic subaortic stenosis. 
  • Spectrum of humoral rejection after pediatric heart transplantation. 
  • Stability of multilead ST-segment "fingerprints" over time after percutaneous transluminal coronary angioplasty and its usefulness in detecting reocclusion. 
  • Stability over time of circadian rhythm of variability of heart rate in patients with stable coronary artery disease. 
  • Standard versus low-dose weight-adjusted heparin in patients treated with the platelet glycoprotein IIb/IIIa receptor antibody fragment abciximab (c7E3 Fab) during percutaneous coronary revascularization. PROLOG Investigators. 
  • Statin therapy--time to turn the focus from efficacy to implementation? 
  • Statin use and stroke outcomes in the Heart and Estrogen-Progestin Replacement Study (HERS). 
  • Statins after intracerebral hemorrhage: to treat or not to treat. 
  • Statins and atherosclerotic cardiovascular outcomes in patients on incident dialysis and with atherosclerotic heart disease. 
  • Statins do not affect platelet inhibition with clopidogrel during coronary stenting. 
  • Statins for secondary stroke prevention in patients without known coronary heart disease: the jury is still out. 
  • Statistical methods for the time-to-event analysis of individual participant data from multiple epidemiological studies. 
  • Steroids for restenosis: strike three! 
  • Storing paraformaldehyde-fixed whole blood patient samples after chronic platelet glycoprotein IIb/IIIa blockade: core laboratory considerations. 
  • Stress and silent myocardial ischemia. A new research study at Duke University Medical Center. 
  • Stress cardiac MR imaging compared with stress echocardiography in the early evaluation of patients who present to the emergency department with intermediate-risk chest pain. 
  • Stress echocardiography in women. 
  • Stress proteins and cardiovascular disease. 
  • Subvalvular thrombotic obstruction of an aortic porcine heterograft. 
  • Sudden death due to coronary artery disease. A clinical, hemodynamic, and angiographic profile. 
  • Summaries for patients. Trends in the use of stress testing to diagnose coronary heart disease. 
  • Supraventricular conduction abnormalities following cardiac operations. A complication of inadequate atrial preservation. 
  • Surgical survival benefits for coronary disease patients with left ventricular dysfunction. 
  • Surgical therapy for coronary disease: randomized and observational studies. 
  • Surrogate assessment of coronary artery disease patients' functional capacity. 
  • Surrogates, substudies, and real clinical end points in trials of drug-eluting stents. 
  • Survival in medically treated coronary artery disease. 
  • Survival of coronary artery disease patients with stable pain and normal left ventricular function treated medically or surgically at Duke University. 
  • Survival prognosis and surgical management of ischemic mitral regurgitation. 
  • Sustained blood pressure control and coronary heart disease, stroke, heart failure, and mortality: An observational analysis of ALLHAT. 
  • Sustained suppression of ischemic complications of coronary intervention by platelet GP IIb/IIIa blockade with abciximab: one-year outcome in the EPILOG trial. Evaluation in PTCA to Improve Long-term Outcome with abciximab GP IIb/IIIa blockade. 
  • Sustained ventricular arrhythmias among patients with acute coronary syndromes with no ST-segment elevation: incidence, predictors, and outcomes. 
  • Sympathoadrenergic mechanisms in reduced hemodynamic stress responses after exercise. 
  • Targeting cardiovascular risk associated with both low density and high density lipoproteins using statin-niacin combination therapy. 
  • Targeting depression interviewing. 
  • Targeting lifestyle change in patients with depression. 
  • Task Force III: Assessment of psychological status in patients with ischemic heart disease. 
  • Tc-99m sestamibi cardiac SPECT imaging during coronary artery occlusion in humans: comparison with dipyridamole stress studies. 
  • Techniques and benefits of multiple internal mammary artery bypass at 20 years of follow-up. 
  • Techniques for real-time two-dimensional echocardiography. 
  • Technology evaluation: VEGF165 gene therapy, Valentis Inc. 
  • Technology insight: MRI of the myocardium. 
  • Temporal Changes in the Association Between Modifiable Risk Factors and Coronary Heart Disease Incidence. 
  • Temporal trends in U. S. multiple cause of death mortality data: 1968 to 1977. 
  • Temporal trends in the use of early cardiac catheterization in patients with non-ST-segment elevation acute coronary syndromes (results from CRUSADE). 
  • Temporary balloon occlusion of the inferior vena cava for immediate reversal of acute pulmonary edema. 
  • Tezosentan in patients with acute heart failure and acute coronary syndromes: design of the Randomized Intravenous Tezosentan study (RITZ-4). 
  • Tezosentan in patients with acute heart failure and acute coronary syndromes: results of the Randomized Intravenous TeZosentan Study (RITZ-4). 
  • Thallium-201 myocardial imaging in patients with coronary artery disease: comparison of intravenous adenosine and oral dipyridamole. 
  • The Association of Sport and Exercise Activities With Cardiovascular Disease Risk: The Atherosclerosis Risk in Communities (ARIC) Study. 
  • The CHD challenge: comparing four cost-effectiveness models. 
  • The Cook-Medley hostility scale: item content and ability to predict survival. 
  • The Internet Tracking Registry of Acute Coronary Syndromes (i*trACS): a multicenter registry of patients with suspicion of acute coronary syndromes reported using the standardized reporting guidelines for emergency department chest pain studies. 
  • The Mini Mental State Exam as a predictor of neuropsychological functioning after cardiac surgery. 
  • The Society of Thoracic Surgeons: 30-day operative mortality and morbidity risk models. 
  • The added value of simultaneous myocardial perfusion and left ventricular function. 
  • The apolipoprotein E epsilon2 allele and aging-associated health deterioration in older males. 
  • The association between self-rated health and mortality in a well-characterized sample of coronary artery disease patients. 
  • The association of dyslipoproteinemia with corneal arcus and xanthelasma. The Lipid Research Clinics Program Prevalence Study. 
  • The benefit of abciximab in percutaneous coronary revascularization is not device-specific. 
  • The cardiovascular disease continuum validated: clinical evidence of improved patient outcomes: part I: Pathophysiology and clinical trial evidence (risk factors through stable coronary artery disease). 
  • The cardiovascular disease continuum validated: clinical evidence of improved patient outcomes: part II: Clinical trial evidence (acute coronary syndromes through renal disease) and future directions. 
  • The changing profile of patient selection, procedural techniques, and outcomes in excimer laser coronary angioplasty. Participating Investigators of the Percutaneous Excimer Laser Coronary Angioplasty Registry. 
  • The changing survival benefits of coronary revascularization over time. 
  • The determinants of activated partial thromboplastin time, relation of activated partial thromboplastin time to clinical outcomes, and optimal dosing regimens for heparin treated patients with acute coronary syndromes: a review of GUSTO-IIb. 
  • The diagnostic and prognostic significance of coronary artery calcification. A report of 800 cases. 
  • The editor's roundtable: management and treatment of non-ST-segment elevation in acute coronary syndromes. 
  • The effect of aprotinin on outcome after coronary-artery bypass grafting. 
  • The effect of aspirin dosing on platelet function in diabetic and nondiabetic patients: an analysis from the aspirin-induced platelet effect (ASPECT) study. 
  • The effect of chronic azithromycin therapy on soluble endothelium-derived adhesion molecules in patients with coronary artery disease. 
  • The effect of crossovers on estimates of survival in medically treated patients with coronary artery disease. 
  • The effect of intra-aortic balloon counterpulsation on coronary blood flow velocity distal to coronary artery stenoses. 
  • The effect of major depression on functional status in patients with coronary artery disease. 
  • The effectiveness of personalized coronary heart disease and stroke risk communication. 
  • The effects of a tailored cardiac rehabilitation program on depressive symptoms in women: A randomized clinical trial. 
  • The effects of coronary revascularization on left ventricular function in ischemic heart disease. 
  • The effects of dopamine on myocardial functional recovery after reversible ischemic injury. 
  • The evaluation of chest pain in women. 
  • The evolution of medical and surgical therapy for coronary artery disease. A 15-year perspective. 
  • The failure of orally administered glycoprotein IIb/IIIa inhibitors to prevent recurrent cardiac events. 
  • The hemodynamic and renal effects of sevoflurane and isoflurane in patients with coronary artery disease and chronic hypertension. Sevoflurane Ischemia Study Group. 
  • The heritability of CHD mortality in danish twins after controlling for smoking and BMI. 
  • The impact of coronary artery disease on carotid endarterectomy. 
  • The impact of emergency department structure and care processes in delivering care for non-ST-segment elevation acute coronary syndromes. 
  • The impact of environmental tobacco smoke on women's risk of dying from heart disease: a meta-analysis. 
  • The impact of medication use in a multicomponent intervention: results from the WISEWOMAN program. 
  • The impact of race on the acute management of chest pain. 
  • The impact of statistical adjustment on economic profiles of interventional cardiologists. 
  • The impact of the format of graphical presentation on health-related knowledge and treatment choices. 
  • The importance of family history in cerebrovascular disease. 
  • The importance of work-up (verification) bias correction in assessing the accuracy of SPECT thallium-201 testing for the diagnosis of coronary artery disease. 
  • The influence of angiographically demonstrated coronary collaterals on the results of stress echocardiography. 
  • The influence of peripheral arterial disease on outcomes: a pooled analysis of mortality in eight large randomized percutaneous coronary intervention trials. 
  • The inhibited power motive, type A behavior, and patterns of cardiovascular response during the structured interview and Thematic Apperception Test. 
  • The kinetics of integrilin limited by obesity: a multicenter randomized pharmacokinetic and pharmacodynamic clinical trial. 
  • The last word on GUSTO, for now. 
  • The manner of death in coronary artery disease. 
  • The natural history of coronary artery disease: an update on surgical and medical management. 
  • The natural history of single-vessel chronic coronary occlusion: a 25-year experience. 
  • The nature of treatment selection in coronary artery disease. Experience with medical and surgical treatment of a chronic disease. 
  • The nonhuman primate model of the relationship between gonadal steroids and coronary heart disease. 
  • The noninvasive localization of ventricular pacing sites by radionuclide phase imaging. 
  • The noninvasive prediction of cardiac mortality in men and women with known or suspected coronary artery disease. Economics of Noninvasive Diagnosis (END) Study Group. 
  • The potential impact of nonpharmacologic population-wide blood pressure reduction on coronary heart disease events: pronounced benefits in African-Americans and hypertensives. 
  • The prognostic significance of 50% coronary stenosis in medically treated patients with coronary artery disease. 
  • The prognostic spectrum of left main stenosis. 
  • The relation between clinical features, angiographic findings, and the target lesion revascularization rate in patients receiving the endeavor zotarolimus-eluting stent for treatment of native coronary artery disease: an analysis of ENDEAVOR I, ENDEAVOR II, ENDEAVOR II Continued Access Registry, and ENDEAVOR III. 
  • The relation of psychosocial dimensions of work with coronary heart disease risk factors: a meta-analysis of five United States data bases. 
  • The relationship between cholesterol level and myocardial infarction or mortality risk in patients with coronary artery disease. A report from the Coronary Artery Surgery Study (CASS) registry. 
  • The relationship between self-rated health and health status among coronary artery patients. 
  • The relationship of transmural myocardial blood flow to midwall function. 
  • The relevance of tissue angiotensin-converting enzyme: manifestations in mechanistic and endpoint data. 
  • The restricted cubic spline as baseline hazard in the proportional hazards model with step function time-dependent covariables. 
  • The role of cardiac risk factor burden in diagnosing acute coronary syndromes in the emergency department setting. 
  • The role of glycoprotein IIb/IIIa platelet inhibition in percutaneous coronary intervention in the stent era. 
  • The role of platelet receptors and adhesion molecules in coronary artery disease. 
  • The role of the exercise test in the evaluation of patients for ischemic heart disease. 
  • The role of the perfusion balloon catheter after an initially unsuccessful coronary intervention. 
  • The significance of coronary calcification detected by fluoroscopy. A report of 360 patients. 
  • The significance of elevated troponin T in patients with nondialysis-dependent renal insufficiency: a validation with coronary angiography. 
  • The structural proteins of normal and diseased human myocardium. 
  • The theory and practice of imaging outcomes research. 
  • The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. 
  • The use of radionuclide angiography in the diagnosis of coronary artery disease--a logistic regression analysis. 
  • The use of the Tracker catheter as a guidewire support device in angioplasty of angulated and tortuous circumflex coronary arteries. 
  • The vulnerable endothelium: priming the vascular endothelium for thrombosis with unfractionated heparin: biologic plausibility for observations from the Superior Yield of the New Strategy of Enoxaparin, Revascularization and GlYcoprotein IIb/IIIa Inhibitors (SYNERGY) trial. 
  • Therapeutic value of eptifibatide at community hospitals transferring patients to tertiary referral centers early after admission for acute coronary syndromes. PURSUIT Investigators. 
  • Therapy and clinical trials. 
  • Therapy for mental stress-induced myocardial ischemia--reply. 
  • Thrombolysis in unstable angina. Randomized double-blind trial of t-PA and placebo. 
  • Thrombosis and drug-eluting stents: an objective appraisal. 
  • Thrombospondin-4 polymorphism (A387P) predicts cardiovascular risk in postinfarction patients with high HDL cholesterol and C-reactive protein levels. 
  • Thrombus imaging with indium-111 platelets. 
  • Ticagrelor with or without Aspirin in High-Risk Patients after PCI. 
  • Time to treatment with thrombolytic therapy: determinants and effect on short-term nonfatal outcomes of acute myocardial infarction. Canadian GUSTO Investigators. Global Utilization of Streptokinase and + PA for Occluded Coronary Arteries. 
  • Transient alterations of the QRS complex and ST segment during percutaneous transluminal balloon angioplasty of the left anterior descending coronary artery. 
  • Transient alterations of the QRS complex and ST segment during percutaneous transluminal balloon angioplasty of the right and left circumflex coronary arteries. 
  • Transient ischemic attacks in a man with coronary artery disease: two strategies neck and neck. 
  • Transluminal intracoronary reperfusion catheter: a device to maintain coronary perfusion between failed coronary angioplasty and emergency coronary bypass surgery. 
  • Transmyocardial laser revascularization for inoperable coronary artery disease. 
  • Transmyocardial laser revascularization limits in vivo adenoviral-mediated gene transfer in porcine myocardium. 
  • Transmyocardial laser revascularization: an anesthetic perspective. 
  • Transmyocardial laser revascularization: experimental and clinical results. 
  • Treating menstruating women with thrombolytic therapy: insights from the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries (GUSTO-I) trial. 
  • Treating to New Targets (TNT) Study: does lowering low-density lipoprotein cholesterol levels below currently recommended guidelines yield incremental clinical benefit? 
  • Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United States: Data From the CASCADE-FH Registry. 
  • Treatment disparities in the care of patients with and without diabetes presenting with non-ST-segment elevation acute coronary syndromes. 
  • Treatment effects of eptifibatide in planned coronary stent implantation in patients with chronic kidney disease (ESPRIT Trial). 
  • Treatment of Anxiety in Patients With Coronary Heart Disease: A Systematic Review. 
  • Treatment of Higher-Risk Patients With an Indication for Revascularization: Evolution Within the Field of Contemporary Percutaneous Coronary Intervention. 
  • Treatment of coronary artery disease in cancer survivors: an emerging challenge. 
  • Treatment of hyperlipidemia by specialists versus generalists as secondary prevention of coronary artery disease. 
  • Treatment of long coronary artery narrowings with long angioplasty balloon catheters. 
  • Treatment of non-ST-elevation acute coronary syndrome in the elderly: current practice and future opportunities. 
  • Treatment of reinfarction after thrombolytic therapy for acute myocardial infarction: an analysis of outcome and treatment choices in the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries (gusto I) and assessment of the safety of a new thrombolytic (assent 2) studies. 
  • Trends from 1987 to 2004 in sudden death due to coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) study. 
  • Trends in emergency coronary artery bypass grafting after percutaneous coronary intervention, 1994-2003. 
  • Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies. 
  • Troponin T and quantitative ST-segment depression offer complementary prognostic information in the risk stratification of acute coronary syndrome patients. 
  • Troponin T levels and risk of 30-day outcomes in patients with the acute coronary syndrome: prospective verification in the GUSTO-IV trial. 
  • Troponin-T and N-terminal pro-B-type natriuretic peptide predict mortality benefit from coronary revascularization in acute coronary syndromes: a GUSTO-IV substudy. 
  • Twelve-lead electrocardiogram recording during percutaneous transluminal coronary angioplasty. Analysis of reciprocal changes. 
  • Two-dimensional echocardiography. 
  • Type A behavior and angiographically documented coronary atherosclerosis in a sample of 2,289 patients. 
  • Type A behavior and survival: a follow-up study of 1,467 patients with coronary artery disease. 
  • Type A behavior pattern and coronary atherosclerosis. 
  • Type A behavior, hostility, and coronary atherosclerosis. 
  • Type A behavior, nonverbal expressive style, and health. 
  • Type As who think they are type Bs: discrepancies between self-ratings and interview ratings of the type A (coronary-prone) behaviour pattern. 
  • Uniform platelet activation exists before coronary stent implantation despite aspirin therapy. 
  • Unimproved chest pain in patients with minimal or no coronary disease: a behavioral phenomenon. 
  • Unrecognized non-Q-wave myocardial infarction: prevalence and prognostic significance in patients with suspected coronary disease. 
  • Unstable angina--report from a Canadian expert roundtable. 
  • Unsticking platelets: the role of glycoprotein IIb/IIIa receptor blockade. 
  • Use of Dual Antiplatelet Therapy and Patient Outcomes in Those Undergoing Percutaneous Coronary Intervention: The ROCKET AF Trial. 
  • Use of a prognostic treadmill score in identifying diagnostic coronary disease subgroups. 
  • Use of aortic counterpulsation to improve sustained coronary artery patency during acute myocardial infarction. Results of a randomized trial. The Randomized IABP Study Group. 
  • Use of both internal thoracic arteries in diabetic patients increases deep sternal wound infection. 
  • Use of common antiplatelet drugs for vascular diseases. 
  • Use of evidence-based medical therapy in patients undergoing percutaneous coronary revascularization in the United States, Europe, and Canada. Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT-I) and Canadian Coronary Atherectomy Trial (CCAT) investigators. 
  • Use of global coronary heart disease risk assessment in practice: a cross-sectional survey of a sample of U.S. physicians. 
  • Use of peripheral arterial tonometry in detection of abnormal coronary flow reserve. 
  • Use of the perfusion balloon as a primary dilation device. 
  • Usefulness of ST depression with T-wave inversion in leads V(4) to V(6) for predicting one-year mortality in non-ST-elevation acute coronary syndrome (from the Electrocardiographic Analysis of the Global Use of Strategies to Open Occluded Coronary Arteries IIB Trial). 
  • Usefulness of an elevated troponin-I in predicting clinical events in patients admitted with acute heart failure and acute coronary syndrome (from the RITZ-4 trial). 
  • Usefulness of diabetic retinopathy as a marker of risk for thallium myocardial perfusion defects in non-insulin-dependent diabetes mellitus. 
  • Usefulness of dobutamine echocardiography for detecting restenosis after percutaneous transluminal coronary angioplasty. 
  • Usefulness of exercise electrocardiography and thallium scintigraphy in unstable angina pectoris in predicting the extent and severity of coronary artery disease. 
  • Usefulness of serial radionuclide angiography in predicting cardiac death after coronary artery bypass grafting and comparison with clinical and cardiac catheterization data. 
  • Using college alumni populations in epidemiologic research: the UNC Alumni Heart Study. 
  • Using observational data to estimate prognosis: an example using a coronary artery disease registry. 
  • Utilizing propensity scores to estimate causal treatment effects with censored time-lagged data. 
  • Validity of the type A construct: a reprise. 
  • Value of exercise treadmill testing in women. 
  • Value of serial troponin T measures for early and late risk stratification in patients with acute coronary syndromes. The GUSTO-IIa Investigators. 
  • Value of the history and physical in identifying patients at increased risk for coronary artery disease. 
  • Variability of 3D arterial geometry and dynamics, and its pathologic implications 
  • Variability of body weight and health outcomes in the Framingham population. 
  • Variation in ventilation time after coronary artery bypass grafting: an analysis from the society of thoracic surgeons adult cardiac surgery database. 
  • Vascular age: integrating carotid intima-media thickness measurements with global coronary risk assessment. 
  • Visit-to-Visit Glycemic Variability and Risks of Cardiovascular Events and All-Cause Mortality: The ALLHAT Study. 
  • Visit-to-visit variability of blood pressure and cardiovascular outcomes in patients with stable coronary heart disease. Insights from the STABILITY trial. 
  • Visual field loss after macular hole surgery. 
  • We need further studies for the development of "optimized antiplatelet therapy" based on ethnicity. 
  • Weighting composite endpoints in clinical trials: essential evidence for the heart team. 
  • When Something is Better Than Nothing: Response to Tully and Cosh. 
  • When innovative therapies make economic sense: economic analysis of enoxaparin versus unfractionated heparin in the ESSENCE trial--an overview. Efficacy and Safety of Subcutaneous in non-Q Wave Coronary Events. 
  • Which beta-blocker for heart failure? 
  • Women's willingness to accept perceived risks for vasomotor symptom relief. 
  • [Canadian Consensus Conference on Coronary Thrombolysis--current aspects]. 
  • [Computed tomography with thallium-201 and oral dipyridamole in the diagnosis of coronary artery disease]. 
  • [Coronary disease]. 
  • [Is coronary magnetic resonance angiography already a clinically useful diagnostic tool?]. 
  • [Laser coronary angioplasty. Critical analysis of the first patients]. 
  • [Psychosocial factors in coronary heart disease -- scientific evidence and recommendations for clinical practice]. 
• 

  Keywords of People

  • Alexander, John Hunter Peel, Professor of Medicine, Medicine, Cardiology
  • Dodge, Kenneth A., William McDougall Distinguished Professor of Public Policy Studies, Duke Science & Society
  • Georgiades, Anastasia, Research Scientist, Psychology & Neuroscience
  • Jones, William Schuyler, Associate Professor of Medicine, Medicine, Cardiology
  • Milano, Carmelo Alessio, Joseph W. and Dorothy W. Beard Distinguished Professor of Experimental Surgery, Surgery, Cardiovascular and Thoracic Surgery
  • O'Connor, Christopher Michael, Adjunct Professor in the Department of Medicine, Medicine, Clinical Pharmacology
  • Olsen, Maren Karine, Professor of Biostatistics & Bioinformatics, Biostatistics & Bioinformatics
  • Starmer, Charles Franklin, Professor Emeritus of Computer Science, Computer Science
  • Yancy Jr., William Samuel, Professor of Medicine, Medicine, General Internal Medicine